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Many organic compounds are chiral and they are useful because of the biological 
activities associated with them. The biological activities of chiral compounds are often 
linked to absolute configuration, i.e. a compound and its mirror image can have different 
biological activities. For example, one enantiomer can be toxic whereas the other 
enantiomer is non-toxic. Enantioselective synthesis plays a significant role in the 
synthesis of biologically active compounds. The activity of tetrahydroisoquinolines 
prompted us to investigate the stereoselective synthesis of selected 1-substituted 
tetrahydroisoquinolines. 
The objectives of this project were to investigate stereoselective synthesis of some 1-
substituted tetrahydroisoquinolines and compare different chiral auxiliaries used in the 
Bischler-Napieralski and Pictet-Spengler reactions and finally to optimize the number of 
steps needed to prepare the target compounds. The main challenge encountered in the 
Pictet-Spengler method was the decomposition of the phenylacetaldehyde. The 
successfully used method was the Bischler-Napieralski reaction because it does not 
involve the use of a phenylacetaldehyde.  
Using the Bischler-Napieralski method, non-stereoselective and stereoselective syntheses 
of tetrahydroisoquinolines have been achieved. The racemic tetrahydroisoquinolines have 
been synthesized in a three-step procedure starting from 3,4-dimethoxyphenylethylamine 
whereas the chiral tetrahydroisoquinolines were synthesized from vanillin in a seven-step 
reaction procedure. The R and S enantiomers of α-methylbenzylamine were successfully 
employed in the synthesis of 1-benzyltetrahydroisoquinolines. However, the R-
enantiomer of 1,2,3,4-tetrahydro-1-naphthylamine could be used to form a chiral 
phenylethylamine, while ring closure in a Biscler-Napieralski reaction was not successful  
under similar reaction conditions.  
The diastereoselectivity of the reactions to form the chiral tetrahydroisoquinolines was 





 respectively. The stereochemistry of the final products was found to be similar to that of 
the chiral auxiliary starting material for each of the synthesized chiral 
tetrahydroisoquinolines. Yields for the precursors were good to moderate, especially on 
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BACKGROUND ON ALKALOIDS AND PROJECT OVERVIEW 
 
1.1 Introduction 
Plants synthesize small molecules called alkaloids. The discovery of alkaloids dates back to 
the early 1800’s.1,2 Alkaloids are subdivided according to the basic skeleton type and they 
include, amongst others, indole (1), quinoline (2) and isoquinoline (3).1  Numbering of 3 is 












Isoquinoline alkaloids have drawn the attention of synthetic chemists because of their 
structural diversity and biological activities.  Isoquinoline alkaloids that are substituted with 
a benzyl group in the 1-position are called 1-benzylisoquinolines and are of interest as a 
result of their antimalarial and antitumour activity. Subclasses of isoquinoline alkaloids 
include the benzyltetrahydroisoquinolines (4), which are represented by morphinanes (5), 




























1.2 Biological Activities of Alkaloids 
1.2.1 Malaria 
Isoquinoline-derived compounds such as 9 inhibit the malaria parasite.3 As an 
improvement to existing compounds, tetrahydroquinoline sulfonamides (10) have been 
























Some tetrahydroisoquinolines (THIQ’s) occur as dimers and hence they are called 
bisbenzyltetrahydroisoquinolines (BBIQ’s). Neferine (11), the major BBIQ isolated from 






















Some of the potent BBIQ’s such as funiferine (12) are doubly bridged and inhibit the 







Figure 1.1: Nelumbo nucifera (Nymphaceae). 
 
1.2.3 HIV/AIDS 
Drugs such as the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz 
(13) are used for treating HIV. This treatment is limited by multi-drug resistance (MDR) 
in the human body. In a recent report, polysubstituted THIQ’s (synthesized in a one-pot 
reaction) with potential pharmaceutical and biological importance are described. For 
instance, a derivative of a HIV inhibitor, R-coclaurine (14), 1-(4-methylphenyl)-1,2,3,4-

















   
 
1.3 Multidrug Resistance 
1.3.1 Multidrug Resistance and P-glycoproteins 
Multidrug resistance (MDR) is the defense of a group of cells against a large spectrum of 
drugs with different chemical structures and mechanism of influence on the cell. MDR is 
a problem in the treatment of patients with cancer and infectious diseases like malaria, 
tuberculosis and HIV.  The main course of MDR is a decrease of drug accumulation 





This becomes a problem because most drugs enter the cell by passive diffusion across the 
cell membrane and hence changes in drug influx may be associated with mutations in the 
cell membrane structure.  The membrane-associated proteins like P-glycoproteins (P-gp) 
control the drug influx and efflux and they have been found to be overexpressed in tumor 
cells.10  
 
1.4 Tetrahydroisoquinolines as potential MDR Reversers 
P-gp mediated MDR is one of the major problems in cancer chemotherapy. P-gp is found in 
human tissues such as kidneys, liver, intestine and in the blood and the brain barrier.11 As 
mentioned before, THIQs show a wide range of biological activities.  It has been reported 
that some THIQ-derived substances have a strong potency for inhibiting P-gp coupled with 
minor cytotoxicity.11  For example, B3 (16) is a novel and potent MDR reverser, it inhibits 
P-gp function without producing cardiovascular side effects.12 Natural BBIQ’s such as 

















1.5 Aims and Objectives  
Many organic compounds are chiral and they are useful because of the biological activity 
associated with them. The biological activities of chiral compounds are often linked to the 
absolute configuration, i.e. a compound and its mirror image can have different activities. 














active compounds. The activity of THIQ’s prompted us to investigate the stereoselective 
synthesis of selected 1-substituted tetrahydroisoquinolines. 
The aims of this project were to: 
 Investigate the stereoselective synthesis of 1-substituted tetrahydroisoquinoline 
derivatives 18 and 19 
 Compare different chiral auxiliaries used in the Bischler-Napieralski and Pictet-
Spengler reactions 
 Optimize the number of steps to prepare 18 and 19. 
 


































Table 1.2: R-groups employed for synthesis. 
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SYNTHETIC APPROACHES TO 1-SUBSTITUTED 
TETRAHYDROISOQUINOLINES: A LITERATURE REVIEW 
 
2.1 Introduction  
Several approaches for the synthesis of THIQ’s have been developed in a number of 
laboratories over the last five decades. However, the enantioselective synthesis of these 
compounds remains a challenge. Most naturally occurring 1-substituted THIQ’s possess 
the 1S configuration and only a few have been isolated with the 1R configuration yet the 
two enantiomers have different biological activities. The following paragraphs review the 
synthetic approaches to selected THIQ’s. The focus will be on asymmetric synthetic 
strategies.  
 
2.2 Biosynthesis of Tetrahydroisoquinolines 
An understanding of the biosynthetic pathways plays a major role in the synthesis of 
many natural products since many synthetic pathways mimic biosynthesis. The following 
paragraph outlines the biosynthesis of norcoclaurine (22). 
 
2.2.1 Biosynthesis of (S)-Norcoclaurine (22)  
The biosynthetic pathway to (S)-norcoclaurine (22) proceeds by the enzyme-catalyzed 
condensation of dopamine (20) and 4-hydroxyphenylacetaldehyde (4-HPAA) (21), 
(Scheme 2.1).1,2 These substrates are obtained by decarboxylation and hydroxylation or 


















Scheme 2.1: Biosynthesis of (S)-norcoclaurine (22). 
Relate82d 1-tetrahydroisoquinoline alkaloids include (R)-4'-O-methylcoclaurine (23) and 













2.2.2 An Enzymatic Stereoselective Synthesis of (S)-Norcoclaurine 
This reaction is the stereospecific enzyme-catalyzed Pictet-Spengler condensation of 
dopamine (20) and 4-HPAA (21) [obtained from 3,4-dihydroxyphenylalanine (25)] to 
yield the benzylisoquinoline central precursor (S)-norcoclaurine (22) (Scheme 2.2). This 
synthetic method is highly efficient and guarantees a very good enantioselectivity. The 
enzyme (S)-norcoclaurine synthase (NCS) has been recently identified4 and has shown to 
be an efficient bifunctional catalyst that activates the p-hydroxybenzaldehyde (21) 
substrate and drive the Mannich–type condensation with substrate 20 in an 
enantioselective manner*.2 The enzyme NCN was isolated from plants such as Papaver 
somniferum (opium poppy) and Thalictrum flavum (a common meadow rue).5  
                                                        




















Scheme 1.2: The stereospecific chemoenzymatic synthesis of (S)-norcoclaurine (22) from 
tyrosine (25) and dopamine (20).2 
 
2.3 Synthesis of THIQ’s 
2.3.1 Synthesis of the Isoquinoline Ring 
The synthetic approaches towards THIQ’s can be classified into 5 different types, 
depending on where the final bond is formed.6 The commonly used methods are Type 1 
and Type 5 (Fig. 2.1). Type 1 THIQ is synthesised via Pictet-Spengler and Bischler-
Napieralski reactions.6 These synthetic methods involve a ring closure between the 
benzene ring and the carbon atom that forms C-1 of the resulting THIQ. They allow 
cyclisation reactions and the formation of a stereogenic centre. Type 5 THIQ is 
synthesised via the Pomeranz-Fritstch reaction. Type 2 involves the ring closure between 
the nitrogen atom and C-1. Type 3 is simply a result of a bond formation between C-3 and 
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Type 4 Type 5
 







2.4 Methods for the Asymmetric Synthesis of Tetrahydroisoquinolines 
THIQ alkaloids are heterocyclic compounds found in many natural and synthetic 
products. They are well known for their biological activities such as antiarrhythmic, 
angiotensin-converting enzyme activity, antihypertensive, antitumor,7 antimicrobial, 
antiplasmodial, non-competitive inhibition to AMPA receptor and anti-depression 
activities.8 They are valuable in synthetic chemistry because they are utilised as synthetic 
intermediates in a wide range of substances.  
A number of synthetic methods are employed in the asymmetric synthesis of 1-subsituted 
tetrahydroisoquinolines. These methods include:   
 Bischler-Napieralski reaction 
 Pictet-Spengler reaction  
 Pomeranz-Fritsch reactions 
 Metal-catalyzed cyclisation 
Asymmetric synthesis is based on the stereo modification of these traditional methods and 
addresses the absolute configuration of the final product. The following paragraphs 
discuss these synthetic methodologies in detail. 
 
2.4.1 Bischler-Napieralski Reaction 
This reaction was discovered in 1893 by August Bischler and Bernard Napieralski.9 It 
makes use of phenylamines and carboxylic acids or acid chlorides as the starting 
materials to give the acetamide (26). Common condensing agents such as phosphorus 
pentoxide (P2O5), phosphorus oxychloride (POCl3) and phosphorus pentachloride (PCl5) 
are used to form the 3,4-dihydroisoquinoline 27, which is then reduced to the 
corresponding THIQ (28) (Scheme 2.3).10,11 The reduction step determines the 
stereochemical outcome of the reaction and can be achieved either by diastereoselective 














P2O5or POCl3 or PCl5 Diastereoselective or 
Enantioselective 
reduction
R = OMe, OBn




Scheme 2.2: Representative Bischler-Napieralski reaction. 
 
2.4.1.1 Diastereoselective Bischler-Napieralski Reactions 
The use of 3,4-dihydroisoquinolinium salts (32) have been found to give excellent results 
in diastereoselective Bischler-Napieralski reactions.12 (+)-(S)-Salsolidine (34) and (S)-
norlaudanosine (35) were prepared in a four-step reaction sequence starting from a 
condensation reaction of 3,4-dimethoxyphenylacetyl chloride (29) and α-
methylbenzylamine (30) in the THF solution of BH3 to give 31 in 90% yield (Scheme 
2.4).13 N-acylation reaction followed by the Bischler-Napieralski cyclisation afforded the 
chiral dihydroisoquinolinium salt (32) which then afforded the tetrahydroisoquinoline 
(33) upon reduction with NaBH4 in 90-94% diastereoselectivity. Catalytic hydrogenolysis 







O 1. Et3N, DMAP, CH2Cl2, rt





1. Et3N, DMAP,  
CH2Cl2, rt, 





































Scheme 2.3: Diastereoselective synthesis of (+)-(S)-salsolidine (34) (S)-norlaudanosine 
(35).13 
 
2.4.1.2 Enantioselective Bischler-Napieralski Reactions 
The Bischler-Napieralski enantioselective synthesis of 1-substituted THIQ’s occurs via 
enantioselective reduction of the resulting prochiral dihydroisoquinoline. This is achieved 
by the use of a chiral hydride reducing agent or hydrogenation in the presence of a chiral 
catalyst. Morimoto et al.16 reported the enantioselective synthesis of (S)-(+)-calycotomine 
(40) that was accomplished by employing catalytic asymmetric hydrogenation of the 
dihydroisoquinoline 38 with 0.5 mol % of an iridium (I) complex of (R)-BINAP in the 

























2-5 oC in toluene-MeOH










Scheme 2.4: Enantioselective synthesis of (S)-(+)-calycotomine (40) by Morimoto et al.16 
 
The amide 37 was prepared from a commercially available 3,4-
dimethoxyphenylethylamine (36) with benzyloxyacetyl chloride in the presence of 
potassium carbonate under biphasic conditions in ether and water. Heating of the amide in 
POCl3 in toluene formed 1-benzyloxymethyl-3,4-dihydro-6,7-dimethoxyisoquinoline 
(38), which was transformed to 39 by asymmetric hydrogenation. The final product 40 
was obtained in 93% yield, 86% ee via the hydrogenolysis of the O-benzyl group in the 
presence of Pd(OH)2-C.  
 
2.4.2 Pictet-Spengler Reaction 
This reaction was discovered by Amè Pictet and Theodor Spengler in 1911.17 It is one of 
the most important and convenient methods as it forms a stereogenic centre 
simultaneously with the ring closure. In the syntheses that have been carried out in an 
asymmetric manner, the chirality transfer occurred from the chiral auxiliary attached to 
either the β-arylethylamine (41) or the aldehyde (42) component, thus involving a 
diastereoselective synthesis as shown in Scheme 2.6.17 The resulting imine (43) 





















R = OMe, OBn






Scheme 2.5: Representative Pictet-Spengler reaction. 
The enantiospecific and stereoselective synthesis of (+)-crispine18 (46) was achieved via 
Pictet-Spengler reaction in 32% yield (Scheme 2.7).19 This naturally occurring compound 
was synthesized from commercially available (R)-(-)-methyl-2-amino-3-(3,4-
dimethoxyphenyl)-propanoate (44) and 4-chloro-1,1-dimethoxybutane. Decarboxylation 
of 45 in a three-step procedure afforded 46 and its antipode was prepared in a similar 















Scheme 2.6: Synthesis of (+)-crispine (46).19 
The coupling of the carboxylic acid 47 (Scheme 2.8) with the chiral auxiliaxy amine S-30 
afforded the amide 48 that resulted in S-31 upon reduction. The reaction of the 
intermediate S-31 with chiral actylenic sulfoxide (49) was successfully investigated by 
Yan et al.20 Previous studies have shown that the 3,4-dimethoxyphenylethyl system reacts 
better with the acetylenic sulfoxides containing a strong electron withdrawing group at 
the aromatic moiety. Hence one of the aromatic moieties was substituted with the o-nitro 
group and gave excellent diastereoselectivity upon treatment with TFA to provide the 




















1. (COCl)2, DMF, DCM, rt
2. 
LiAlH4/AlCl3, THF





















Scheme 2.7: Synthesis of THIQ’s 50 and 51 from chiral acetylenic sulfoxides.20 
 
2.4.2.1 Electrochemical Synthesis 
Electrochemistry of natural product has been extensively studied in the later part of the 
20th century.21-23 Pictet-Spengler cyclisation method can be used in conjunction with the 
electrosynthetic strategies to provide the desired tetrahydroisoquinolines. Louafi et al.24 
reported the electrosynthesis of chiral 1-substituted cyanotetrahydroisoquinolines. The 
key steps in this reaction were the Pictet-Spengler cyclisation to give a THIQ as shown in 
Scheme 2.9 (step 1) followed by anodic cyanation (step 2) of the resulting THIQ as 
shown in Scheme 2.10. 
The first step of the synthesis was the conversion of the carboxylic acid 47 to the 
corresponding acid chloride that was condensed with S-30 to afford 48 in 85% yield. 
Reduction of 48 afforded S-31 in 95% yield which was subjected to Pictet-Spengler 
















O1. (COCl)2, CH2Cl2, rt, 12 h
2. NEt3, CH2Cl2
rt, 12 h, 85%
BF3.Et2O, BH3.THF















Scheme 2.8: Pictet-Spengler cyclisation to form 52. 
 
The loss of electron from 52 resulted in the formation of a cationic radical intermediate 
which further undergone a series of reactions to form 55 (Scheme 2.10). The anodic 
oxidation of 53 resulted in the formation of an iminium radical 53 which resulted in 54 
upon stepwise deprotonation and ionization which afforded 55 when subjected to 































2.4.2.2 Metal-catalysed Reactions 
Among various methods used for synthesis of THIQ’s, transition metal catalyzed C-C 
bond formation is considered as one of the modern synthetic strategies.25-27 Nadakumar et 
al.8 reported a two-step palladium catalyzed formation of functionalized THIQ’s in good 
yield.8 The first step (Scheme 2.11) involves a Cu-I catalyzed 3-component coupling 
reaction of an amine 56, an aldehyde 57 and a terminal alkyne 58 to give a 
propargylamine 59. The second step is a regio- and stereoselective palladium catalyzed 6-




1 + R2CHO + R























R1 = H, 4,5-OMe
R2 = Ph, iso-propyl, 4-OMePh























2.4.3 Pomeranz-Fritsch Reaction 
This is a synthetic method for Type 5 THIQ’s involving the cyclization reaction of 
benzylaminoacetal (65) under acid-catalyzed conditions. The original Pomeranz-Fritsch 
reaction method has been improved and modified in many ways.28,29 The most useful 
modification was introduced by Bobbit et al.30 in which 62 was reduced via catalytic 
hydrogenation of the imine C=N double bond and by employing Grignard reagents31 to a 
benzylaminoacetal intermediate 65 before cyclisation.30 The latter Pomeranz-Fritsch-
Bobbit methodology can either be enantioselective by employing external factors to 
induce chirality or diastereoselective by introducing chiral auxiliaries. 
 
2.4.3.1 Enantioselective Pomerenz-Fritsch-Bobbit Reaction 
Głuszyńska et al.32 reported the enantioselective synthesis of (-)-salsolidine (66) and (-)-
carnegine (68)33 by employing the Pomerenz-Fritsch-Bobbit methodology (Scheme 2.12).  
The synthesis started by the condensation of 3,4-dimethoxybenzaldehyde (61) with the 
aminoacetal (62) to give 63. Ligand 64 promote the enantioselective addition of 
methyllithium to the imine double bond to give 65. Enantioselectivity in the addition step 
was achieved by the use of enantiopure oxazolines (64). Compounds 66 and 68 were 

































6M HCl, 1 day, H2/Pd-C























Scheme 2.11: Enantioselective synthesis of (-)-salsolidine (66) and (-)-carnegine (68).32  
 
2.4.3.3 Diastereoselective Pomerenz-Fritsch-Bobbit Reaction 
Sulfinimines have been used in the synthesis of natural products and THIQ’s because of 
their good reactivity and stereoselectivity that is due to the electron-withdrawing 
character of the N-sulfinyl moiety.34  
The enantiomerically pure (R)-(N)-butanesulfinylimine (69) was employed in the 
diastereoselective synthesis of (-)-salsolidine (66) using the Pomeranz-Fritsch-Bobbit 
methodology (Scheme 2.13).35 Compound 67 was prepared in a five-step procedure 





sulfinimine 70 was subjected to methylation with a Grignard reagent to give 71 in 84% 
yield. The ethanolic solution of 71 was subjected to acid hydrolysis to afford the 
intermediate 72 that was acetylated to give the aminoacetal (73) upon purification. The 


























2.4.3 General Approach towards the Synthesis of 1-Substituted THIQ’s 
A general enantioselective strategy has been reported by Amat et al 36 (Scheme 2.14) for 
1-substituted THIQ alkaloids. A number of enantiopure 1-substituted THIQ’s were 
synthesized from a tricyclic lactam (76) that was obtained by the cyclocondensation of an 
ester (74) with (R)-phenylglycinol (75). These include (S)-(-)-salsolidine (66), (-)-crispine 









































Scheme 2.13: THIQ’s prepared from tricyclic lactam scaffold (76).36 
 
2.5 Conclusion 
This chapter reviews a variety of methods towards the synthesis of THIQ’s starting from 
the biosynthesis up to the asymmetric synthesis of THIQ’s. It has been noted that the 
asymmetric synthesis of THIQ’s has constantly developed over the years. The advantage 
of the asymmetric synthesis is that it provides both R and S configurated compounds in 
good yields whereas the biosynthesis only allows the isolation of small amounts of the 
compounds and most of them possess the 1S configuration. Modification of the traditional 
methods for the asymmetric synthesis of THIQ’s has been a great success in the 
enantioselective synthesis of these compounds. These methods give good to excellent 
yields of compounds and also provide the general approach for the synthesis of THIQ’s in 
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RESULTS AND DISCUSSION 
 
3.1 Introduction  
The Pictet-Spengler and Bischler-Napieralski reactions are widely used in the synthesis of 
THIQ’s. The key reagent in both these reactions is a 2-arylethylamine. By attaching a 
chiral auxiliary to the amine, stereoselective syntheses of THIQ’s become feasible. This 
Chapter discusses the application of the above-mentioned reactions in the preparation of 
18 and 19.  
The preparation of the 2-arylethylamine often requires a large number of steps and the 
first aim was to attempt to minimize the number of steps in the preparation of this 
intermediate. The second aim was to compare chiral auxiliaries for the synthesis of 
enantiopure THIQ’s. As a first step, a retrosynthetic analysis was performed on 19, as is 
explained in the paragraph below. 
 
3.2 Retrosynthetic Analysis 
For the synthesis of compound 18 (Scheme 3.1), with either the R or S configuration at C-1, 
the disconnection at bond a leads to β-phenethylamine 31 and phenylacetaldehyde 78. A 
second disconnection at b affords 79 and the chiral amine 30. Phenylacetaldehyde 79 can be 
prepared from eugenol (80) by ozonolysis or from 3,4-dimethoxybenzaldehyde (61), which 
is easily prepared from commercially available vanillin. Amine 30 was chosen as the 
standard chiral auxiliary because it is commercially available as both the R- and S-






























Scheme 3.1: Retrosynthetic analysis of 18. 
 
Previous methods used in our research group for the incorporation of the chiral auxiliary 
amine 30 used long synthetic routes (Scheme 3.2).1-3 This route to 1-
benzyltetrahydroisoquinolines (19) was also followed by several other researchers.3,11 
The route consists of six steps which results in a low overall yield although individual 












































The synthesis starts with the conversion of benzaldehyde 81 to the corresponding benzyl 
alcohol 83 which is further converted to chloride 83 and then to cyanide 84. Cyanide 84 
was then converted to carboxylic acid 85 which was condensed with 30 to form the amide 
86, which was reduced to the amine 87.  
 In the synthesis proposed here (Scheme 3.3), the number of steps was reduced to three. The 
problematic steps are the second and the third steps. Phenylacetaldehydes 78 react readily 
under acidic or basic conditions to form polymeric products and therefore the hydrolysis of 
88 to 78 must be performed under carefully controlled conditions to get a good yield of the 
product. A one-pot condensation reaction of 78 and 30 to form 87 will eliminate a number 
of steps. However, this procedure has not been reported for these substrates and the method 
will have to be developed here.  
CHOOH, DCM
1. 99% Et2OH, 12 h
2. NaBH4, 3 h
rt, 12 h
1.5 eq. Ph3PCH2OMeCl, 
2.5 eq. t-BuOK 


















Scheme 3.3: Proposed synthesis of the chiral amine 87. 
 
3.3 Preparation of 3,4-Dimethoxybenzaldehyde (61) 
This is the first step in the synthesis and the goal was to obtain the highest possible yield. 
Different reagents and reaction conditions were explored in order to find the method that 























2.5 eq. K2CO3, 1.5 eq. Me2SO4
2.5 eq. K2CO3, 1.5 eq. Me2SO4
2.5 eq. K2CO3, 1.5 eq. Me2SO4
 
Scheme 3.4: Preparations of 3,4-dimethoxybenzaldehyde (61). 
 
The first choice for the starting material was 3,4-dihydroxybenzaldehyde (89) that was 
commercially available, albeit expensive. It was anticipated that the free hydroxyl groups 
would be easily methylated to give the desired product in a good yield. However, 
methylation of 89 in anhydrous acetone and K2CO3 using dimethyl sulfate (Me2SO4) gave 















The low yield of this reaction was attributed to the formation of the other two by-products 
(from the TLC) which could be the 3-monomethylated (90) and the 4-monomethylated (91) 
products. The low selectivity of this reaction under these reaction conditions prompted us to 
consider alternative starting materials and vanillin (90) was used as starting material for 
subsequent reactions. By changing the solvent to acetonitrile, a 98% yield of product 61 
was obtained. The mechanism for this reaction is illustrated in Scheme 3.5.      




















Scheme 3.5: The SN2 reaction between vanillin (90) and dimethyl sulfate. 
 
 
The structure of 3,4-dimethoxybenzaldehyde (61) was confirmed by 1H NMR, 13C NMR 
and 2D NMR. The 1H NMR spectrum displays two sharp singlets for the two methoxy 
groups resonating at δH 3.97 and δH 3.99, and three aromatic protons resonating at δH 7.00, 
δH 7.41 and δH 7.46. The coupling constants of the three aromatic protons show that they 
form an ABX spin system, one proton at δH 7.00 (d, J = 8.3 Hz, ortho coupling, H-5), 
proton at δH 7.41 (d, J = 1.9 Hz, meta coupling, H-2) and the proton at δH 7.46 (dd, J = 8.3 
and 1.9 Hz, ortho and meta coupling, H-6). The aldehyde proton was observed at δH 9.86 as 
a singlet. Assignment of the signals at δC 56.0 and 56.2 to the two methoxy groups, δC 
109.1, 110.5 and 126.8 to C-2, C-5, and C-6, respectively, and δC 190.0 to the aldehyde 































Figure 3.1: HMBC correlations observed for 3,4-dimethoxybenzaldehyde (61). 
 
The non-protonated carbons display signals at δC 149.7, 154.5 and 130.2. These signals 
were assigned using an HMBC spectrum as it is able to show signals for protons coupled to 
carbons that are multiple bonds away.  HA is coupled to both C-3 and C-4 but shows strong 
correlation with C-3 while on the other hand HB shows strong correlation with C-4 but not 
coupled to C-3 (Fig. 3.1). HX also shows a strong correlation with C-4. The signal at δC 





130.2 was assigned to C-1. The IR spectrum shows a medium to strong peak at 1732 cm-1 
which is in accordance with the literature value (1740-1720 cm-1)  for the aldehyde C=O 
bond.4  
 
3.4 Preparation of the Phenylacetaldehyde (79) 
3.4.1 Preparation of 3,4-Dimethoxy-1-(2-methoxyethenyl)benzene (92) 
Conversion of 3,4-dimethoxybenzaldehyde (61),  to the enol ether 92 was attempted as 
outlined in Scheme 3.6. The first reaction resulted in 23% of the desired product 92 after 
refluxing the reaction mixture for 24 h. It was observed that the reaction was photosensitive 
and exothermic, so the synthesis of this intermediate at higher temperatures and in the 
presence of light was not advisable. Performing the reaction at room temperature for 10 







+Cl-, 2.5 eq t-BuCl
THF, reflux, 24 h, 83%
1.5 eq (MeOCH2PPh3)
+Cl-, 2.5 eq t-BuCl
THF, rt, 24 h, 23%
61 92
 
Scheme 3.6: Preparation of the enol ether (92). 
 
The obtained product 92 gave complex 1H and 13C NMR spectra because it consists of  two 
compounds, cis- and trans-3,4-dimethoxy-1-(2-methoxyethenyl)benzene (92) in equal 
quantities. The 1H NMR spectrum displayed six methoxy singlets at δH 3.67 - 3.88 for the 
cis and trans-products.  The aldehyde singlet at δH 9.77 was no longer observed in the 1H 
NMR spectrum confirming that the aldehyde was successfully converted to the enol ether 
92. Doublets for the vinylic protons were observed at δH 5.17 - 6.06. The mechanism for the 
Wittig reaction is shown in Scheme 3.7. The IR spectrum of the product shows broad 
absorptions at 3063, 2924 and 2850 cm-1 which agree with the reference4 values of 3300-
2700 cm-1  which indicates the presence of the C-H bond. The medium broad signal at 1674 
cm-1 correlates with the literature values (1680-1600 cm-1) indicating the presence of the 
C=C bond. The peaks at 1200 cm-1 to 1070 cm-1 are in accordance with the values listed in 




























Scheme 3.7: The mechanism of the Wittig reaction to form the enol ether (92). 
 
The Wittig reaction was first reported by Wittig and Geissler in 1954.5 It is the most 
recognized method for carbonyl olefination. The mechanism of this reaction involves two 
intermediate species, a di-ionic betaine 93 derived from the phosphonium salt and an 
oxaphosphetane (the intermediate, 94) (Scheme 3.7).6 The reaction of the aldehyde and the 
phosphonium ylide produces both the cis and trans oxaphosphetanes (94) which undergoes 



















trans- isomer cis- isomer
A
 
Figure 3.2: HSQC correlations for the cis and trans- isomers of compound 92. 
 
The olefinic coupling constants (J) in the 1H NMR spectrum show that both the cis and the 
trans isomers are present. This is shown by a large J value for the olefinic protons that 





The HSQC spectrum shows the carbon signals of CH=CHOMe at δC 104.8 for the trans 
system and at δC 105.6 for the cis system. C-4 was assigned to at δC 148.6 for cis since it 
shows a strong correlation with HB of the cis system and therefore δC 149.0 belongs to the 
trans system. 
 
3.4.2 Hydrolysis of Enol Ether 92 
Having successfully prepared the enol ether 92, the next step involved the synthesis of 3,4-
dimethoxyphenylacetaldehyde 79 (Scheme 3.8). The reaction conditions for this reaction 
are very critical because phenylacetaldehydes are not very stable under both basic and 
acidic conditions and easily undergo condensation reactions to yield polymeric products.  
The hydrolysis of the enol ether 92 under mild acidic conditions using 98% HCOOH and 
DCM afforded the acetaldehyde 79 in 71% yield.  The formation of this compound could 
only be confirmed using 1H NMR shortly after preparation since it is very unstable and 
could not be kept for longer experiments. The 1H NMR displays a triplet at δH 9.77 which 







rt, 12 h, 71%
92 79
 
Scheme 3.8: Synthesis of 3,4-dimethoxyphenylacetaldehyde (79). 
 
The method for the preparation of the acetaldehyde was changed so that acidic conditions 
were avoided. The alternative method required the conversion of 3,4-
dimethoxybenzaldehyde (61) to 3,4-dimethoxyvinylbenzene (95) as an intermediate. The 
3,4-dimethoxyvinylbenzene (95) was converted to the corresponding alcohol (96) by 
hydroboration of the styrene intermediate. The alcohol was then oxidized to the 
corresponding acetaldehyde by Swern oxidation or the use of o-Iodoxybenzoic acid 

















+ I-, 30 min
 BuLi, THF, 12 h, 52%
 
Scheme 3.9: Synthesis of 3,4-dimethoxyvinylbenzene (95). 
 
The vinylbenzene (95) was prepared from 61 in 52% yield (Scheme 3.9). The product 
was obtained as light yellow oil. The Wittig reaction was performed using 
methyltriphenylphosphonium iodide and butyllithium. The structure of 95 was confirmed 
using 1H NMR, 13C NMR and 2D NMR spectra. The 1H NMR shows three signals for the 
vinylic protons, the signal at δH 5.15 for HC=CH2 (cis) was a doublet with a coupling 
constant of 10.9 Hz, the signal at δH 5.61 for HC=CH2 (trans) was also splitted into a 
doublet and HC=CH2 was splited into a doublet of doublets at δH 6.68 with coupling 
constants 10.8 and 17.8 Hz. These results are in good agreement with those obtained by 
Sonopo2 for the synthesis of a similar compound.   
 
3.4.4 Preparation of 2-(3,4-Dimethoxyphenyl)ethanol (96) 
Alcohols have been prepared using a number of methodologies. These methods make use 
of a variety of metal catalysts and photo-oxidation has also been employed.7-9 Over-
oxidation needs to be avoided in the alcohol-forming reactions since alcohols can be 
easily oxidized to form the corresponding carboxylic acids.   
The alcohol (96) was prepared by hydroboration of 3,4-dimethoxyvinylbenzene (95) 
(Scheme 3.10). However, the yield of this reaction was not satisfactory (33%) although a 
sufficient amount was obtained for the subsequent step. The unsatisfactory yield was due 
to the fact that the reaction itself was not capable of converting all the starting material 
















62. 2 M NaOH (EtOH:H2O,2:1), 
    1.5 eq H2O2, rt, 2 h, 33% 
 
Scheme 3.10: Synthesis of 2-(3,4-dimethoxyphenyl)ethanol (96). 
The structure of the product was verified by NMR experiments, IR and mass 
spectrometry. The 1H NMR spectrum show a triplet at δH 2.81 for the benzylic methylene 
group. A triplet at δH 3.83 with a coupling constant of 6.4 Hz was assigned to the 
methylene protons attached to the alcohol and two singlets at δH 3.86 and δH 3.87 were 
assigned to the two methoxy groups. The shift of the CH2 signal reflects the effect of the 
oxygen atom pulling away the electrons hence deshielding the protons. Other signals 
were observed in the aromatic region, a broad singlet next to a broadened doublet was 
observed at δH 6.77 integrating for two protons H-2 and H-6 respectively and a doublet 
was observed at δH 6.83 integrating for one proton, H-5.  
The carbons were assigned using both 1D NMR and 2D NMR experiments. C-1, C-3 and 
C-4 were observed at δC 131.1, 147.6 and 148.7, respectively. These signals were 
assigned to quaternary carbons because no correlations to proton signals were observed in 
the HSQC. The sp3 carbons resonate at δC 38.8 for CH2CH2OH and at δC 55.8 and 56.0 
for the two methoxy groups and δC 63.8 for CH2CH2OH. The aromatic carbons were 
assigned at δC 116.6 for C-2, δC 112.4 for C-5 and δC 121.1 for C-6.  
Hydroboration was first reported by the Nobel Prize winner, Herbert C. Brown in 1961 as 
a powerful synthetic tool.10 This reaction is defined as the addition of a boron hydride to 
alkenes and alkynes. The addition of borane across a double bond occurs in a concerted 
manner.11 The borane adds concertedly and regioselectively to the alkene 95 with the 
boron atom of the complex 97 bonding to the less substituted carbon of the alkene, giving 
borane 99 (Scheme 3.11). The more controlled oxidation under inert conditions was 
















































1.5 eq. H2O2, 3 M NaOH 
 
Scheme 3.11: The mechanism for the hydration of (3,4-dimethoxyphenyl)ethene (95). 
Hydrogen peroxide was used as the oxidizing agent, it replaces the carbon-boron bond in 
99 with a carbon-oxygen bond to give 100. The addition of aqueous NaOH completes the 
reaction by attacking the intermediate 101 to cleave the B-O-alkyl bond to yield the 
alcohol 96.  
 
3.5 Oxidation of the Alcohol 
3.5.1 Swern Oxidation  
After the successful formation of the alcohol, preparation of the acetaldehyde using the 
Swern oxidation procedure was attempted (Scheme 3.12). However, a mixture of 
inseparable products was obtained. This was established by TLC and in the 1H NMR 
spectrum that was recorded immediately after working up the reaction. The failure of the 













1. 2 eq. (COCl)2, DMSO, 15 min
2. 5 eq. Et3N, -78 
oC
 
Scheme 3.12: Preparation of the phenylacetaldehyde 79. 
 
The reaction is initiated by the reaction of dimethyl sulfoxide and oxalyl chloride at -78°C 
(Scheme 3.13). The resulting intermediate 102 reacts rapidly with the alcohol 96 to form 
the alkoxysulfonium salt 104. The nucleophilic attack of triethylamine (103) on 








































Scheme 3.13: Mechanism for the Swern oxidation. 
 
The Swern oxidation is a well-known method for the preparation of alcohols under mild 
conditions and is known to work well with sterically hindered alcohols.13 In our case the 
lability of the phenylacetaldehyde was a problem. A triplet was observed in 1H NMR 
spectrum at δH 9.77 indicating the presence of the acetaldehyde along with many other 
signals. The IBX oxidation was also explored since IBX is a versatile reagent and is 






3.5.2 IBX Oxidation  
IBX has been extensively employed in the oxidation of alcohols, silyl enol ethers and 
other organic compounds to their corresponding α,β-unsaturated carbonyl compounds.14-
16 Some of the shortcomings for this reagent are that it is explosive and does not dissolve 
in most common polar organic solvents. It usually dissolves in highly polar solvents like 







1. 2 eq IBX, DMSO, 15 min
2. Rt, 5 h
96 79
 
Scheme 3.14: IBX oxidation of the alcohol (96). 
 
For the synthesis of 79 (Scheme 3.14), IBX was dissolved in DMSO and stirred for 15 
minutes at room temperature. DMSO was the solvent of choice since it remarkably 
reduces the acidity of IBX17 that could affect the stability of the product, the aldehyde 
(79). A solution of the alcohol in DMSO was added slowly and the reaction was allowed 
to stir for a further 5 h at room temperature. TLC showed the disappearance of the 
starting material and the 1H NMR spectrum confirms the presence of the product as the 






























The mechanism for the oxidation of alcohols is explained by Su et al.18 to be a 
hypervalent twisting mechanism (Scheme 3.15). The first step in the reaction is the ligand 
exchange reaction where the hydroxyl group of the IBX (105) is replaced by the alcohol 
(96) to form the intermediate (106) that undergoes a twist and an elimination reaction. 
The twisting of the intermediate is required to enable the concerted elimination reaction. 
The elimination step is regarded as the rate-determining step for this reaction that forms 
the product and furthermore, it yields a very stable byproduct called IBA (107).17,19 
Besides the above-mentioned reagents employed for the oxidation of the alcohol, other 
reagents like ceric ammonium nitrate and manganese dioxide were also used to oxidize 
the alcohol 79 with no success.  
 
3.6 (S)-N-[2-(3,4-Dimethoxyphenyl)ethyl]-1-phenylethylamine (31) 
Having prepared the aldehyde (Scheme 3.13), it was condensed with the chiral auxiliary 
amine (S-30) in the next step of the proposed synthetic route (Scheme 3.16). 
Unfortunately, this reaction was not successful despite several attempts. There were 
always multiple products on the TLC of the crude mixture with one dominant spot for the 
starting material (S-30). It was suspected that the phenylacetaldehyde decomposed during 




























It was decided to perform a model reaction for this reaction which involved the reaction 
of commercially available and freshly distilled phenylacetaldehyde (108) and (S)-(α)-
methylbenzylamine (S-30). Several methods for this reaction were attempted to establish 
suitable reaction conditions. The method that provided better results was the reductive 
amination of the phenylacetaldehyde using NaBH4-silica chloride.20 Silica chloride was 
prepared according to a reported procedure.21  









Scheme 3.17: Model reaction for the acetaldehyde (108) and (S)-(α)-methylbenzylamine 
(S-30) 
 
The product (109) was obtained in an unsatisfactory yield of 17% (Scheme 3.17). The 
structure of 109 was confirmed by NMR experiments, IR and MS. The 1H NMR spectrum 
showed a doublet at δH 1.35 for the methyl group, a multiplet at δH 2.79 for the four 
methylene protons, a quartet at δH 3.86 for the methine proton and 10 aromatic protons 
were present as a multiplet at δH 7.24-7.42. The MS results found 226.1593 [M+H]+ 
calculated for C16H20N 226.1596. The optical rotation was measured to be -63.7° at 
ambient temperature. 
The major product in this reaction was the aldol condensation product of the 
phenylacetaldehyde (108). From this result it was clear that the reason for the failure of 
the earlier attempts for this synthesis were due to the self-condensation reactions that 
phenylacetaldehydes are prone to undergo. These reactions may be the reason why none 
of the attempted methods for the synthesis of 31 (Scheme 3.18) provided the expected 
product. Phenylacetaldehydes are prone to disproportionation and condensation raction in 






















Scheme 3.18: Disproportionation pathway of the phenylacetaldehyde (108).1 
 
In the disproportionation pathway 108 produces the alcohol 110 and phenylacetic acid 
(111). The alcohol formed readily dehydrates to form the styrene (112) that polymerizes 
to form the polystyrene when heated. Phenylacetic acid (111) undergoes an aldol 




























In the condensation pathway the first step is the aldol reaction which is accompanied by 
the elimination reaction to produce the β-hydroxyaldehyde 115. In the aldol reaction 108 
loses a proton from the α-carbon thus producing an enolate ion. The enolate ion then 
reacts with 108 in the reaction mixture to form the β-hydroxyaldehyde 115 upon 
protonation of the negatively charged oxygen (Scheme 3.17). Dehydration of the β-
hydroxyaldehyde 115 gave the product 116.4 
The structure of 116 was elucidated using 1H and COSY NMR spectroscopy. The 1H 
NMR spectrum shows a doublet at δH 3.63 for the CHCH2Ph, a triplet at δH 6.80 for the 
vinylic proton, a multiplet for the ten aromatic protons at δH 7.09 – 7.64 as well as the 
aldehyde singlet at δH 9.59. Low resolution mass spectrometry (LRMS) displayed the 
sodium adduct of the formed product, m/z 245.1053 for C18H18NaO3.  
 
3.6.1 Preparation of 2-(3,4-Dimethoxyphenyl)ethyl 4-methylbenzenesulfonate (55) 
After a number of attempts to form 31 from the phenylacetaldehyde 79, it was decided to 
explore a different route that allows the formation of the chiral amines by avoiding the 
use of the phenylacetaldehyde. Tosylation is a well-known method that converts alcohols 
to tosylates and allows subsequent nucleophilic substitution reactions.23 The advantage of 
this method is that it allows the formation of a stable intermediate (alkyl tosylate) with an 








Tosylates (117) are better leaving groups than halides and mesylates and their preparation 
from alcohols avoids skeletal rearrangements and stereochemical ambiguity.24 This 
method has been successfully employed in the preparation of various organic compounds 
without complications. It has been used in the preparation of precursors towards the 
synthesis of selenium analogues of dopamine,25 4-(2-iodoethyl)-1,2-dimethoxybenzene,26 













1.5 eq. TsCl, 
1.2 eq Et3N, 1.5 eq. TsCl, 
dry DCM, rt, 12 h, 37%
11796
 
Scheme 3.20: Preparation of the tosylate (117) from the alcohol (96). 
 
Compound 117 was prepared in a moderate yield of 37%. This may be attributed to the 
fact that the both starting materials were not consumed completely at the end of the 
reaction (Fig. 19). The structure of 117 was confirmed using 1H NMR, 13C NMR, IR and 
high-resolution MS. In the 1H NMR spectra, a noticeable shift of the CH2 was observed at 
δH 3.83 in the alcohol 96 to δH 4.20 in 117. Other characteristic signals were observed at 
δH 2.89 (singlet) for the CH3 protons and δH 2.42 (triplet) for the benzylic methylene and 
seven aromatic protons were observed at the aromatic region from δH 6.60 to δH 7.67. At 
δH 3.80 and 3.84 there were two singlets representing the protons of the two methoxy 
groups. at δH 4.19 there was a triplet representing the CH2 group bonded to the tosylate 
group. In the ESI-TOF mass spectrum using positive ionization, [M+Na]+ was observed at 









Figure 3.3: The TLC plate showing the alcohol 96, the tosylate 117 and tosyl chloride 






3.7 Synthesis of 1-Substituted Tetrahydroisoquinolines 
3.7.1 Preparation of Enantiomerically-pure Tetrahydroisoquinoline Intermediates 
Three enantiopure tetrahydroisoquinoline intermediates were successfully prepared in a 
five-step synthetic route starting from vanillin. This was achieved by introducing chiral 
auxiliaries on the starting materials. The chiral auxiliaries used were (S)-(-)-α-
methylbenzylamine (S-30), (R)-(+)-α-methylbenzylamine (R-30) and (R)-1,2,3,4-
tetrahydronaphthalene. 
 
3.7.2 Preparation of (S)-N-[2-(3,4-Dimethoxyphenyl)ethyl]-1-phenylethanamine (S-
31) 
Alkylation of amines is often problematic. Unlike alkylation of alcohols where only one 
product is possible, alkylation of amines can yield a mixture of products – mono-
alkylated, dialkylated, trialkylate and tetra-alkylated to form quaternary ammonium salts. 
If the product is protonated, it becomes soluble in water and is difficult to extract using an 
organic solvent. To maximize the formation of the monoalkylated amine, it is important 
to keep the concentration of the alkylating agent (tosylate) low. The amine S-31 was 
successfully prepared from the tosylate. The tosylate was slowly added to a stirring THF 



















Scheme 3.21: Preparation of the amine (S-31) to form the tosylate (117). 
 
Characteristic proton signals were observed at δH 1.36 (doublet) indicative of the methyl 
group and a multiplet at δH 2.75 for the four methylene protons. The ABX spin system 
was observed in the aromatic region integrating for three protons as well as a 5-proton 
multiplet for the rest of the aromatic protons. The optical rotation was measured to be 
+37.05° at 25 °C. Both (R) and (S) enantiomers were prepared by employing the same 


















Scheme 3.22: Synthesis of (S)-N-[2-(3,4-dimethoxyphenyl)ethyl]-1,2,3,4-
tetrahydronaphthalen-1-amine (119). 
The tetrahydronaphthalene derivative 118 was reacted with 117 by employing the same 
procedure as in the preparation of S-31. The 1H NMR spectrum signals were in good 
agreement with the structure of the product 119 - the four methylene protons at δH 1.74 of 
the cyclohexane ring, a broad singlet at δH 2.03 for the proton bonded to the nitrogen 
atom and the four methylene protons at δH 2.91-3.01.    
The 13C NMR confirmed the presence of the aromatic quaternary carbons connected to 
the two methoxy groups at δC 147.9 for C-4 and δC 149.1 for C-3. The MS spectrum 
showed a m/z of 312.1974 in the positive ionization mode characteristic of the [M+H]+  
for this compound.  
 
3.7.3 Model reaction and Attempted Pictet-Spengler Cyclization 
After having successfully prepared the benzyltetrahydroisoquinoline intermediate 
compounds, a model reaction was carried out by using the commercially available 
homoveratrylamine and p-anisaldehyde. Both reagents were freshly distilled before use 






1. p-TSA, Ms, DCM, rt, 24 h
2. TFA, reflux, 4 h, 40%+
36 120 121
 







The Pictet-Spengler cyclisation for 36 and 120 afforded the product 121 in 40% yield as a 
yellow oil. The 1H NMR spectrum signal of H-1 was evident at δH 3.81 and also the 
absence of the aldehyde signal proved the occurrence of the reaction. The methylene 
protons signals were observed over a range, δH 2.83 - 3.05. Three methoxy singlets were 
also observed at δH 3.61, 3.75 and 3.85. The quaternary carbon signal for C-4′ appeared 
more downfield (δC 159.6) than the other quaternary carbons, C-6 and C-7 which 
appeared at δC 148.4 and 147.6, respectively. The structure was consistent with the MS 
and IR data, the former showing m/z 300.1605 for [M+H]+ in the positive ionization 
mode. 
Similar reaction conditions were employed for the synthesis of the chiral 
tetrahydroisoquinolines but with no luck since the phenylacetaldehyde (108) immediately 
decomposed in the presence of p-TSA. Multiple spots were observed on the TLC plate. It 
was assumed that the phenylacetaldehyde decomposed according to the mechanism 
explained in Scheme 3.16 and Scheme 3.17. Multiple spots were observed on the TLC 











1. p-TSA, Ms, DCM, rt, 24 h
2. TFA, reflux, 4 h+
S-31 108
 
Scheme 3.24: Attempted synthesis of a chiral THIQ via the Pictet-Spengler cyclisation.  
 
At this stage the alternative method that could be employed in order to synthesize THIQ’s 
was the Bischler-Napieralski cyclisation, even though it adds two more steps in the 
synthesis. A number of tetrahydroisoquinolines were synthesized by using this method. A 
model reaction was performed by synthesizing tetrahydroisoquinolines without the chiral 





















Sat. NaHCO3, DCM:H2O (1:1), 
rt, 12 h, 79%
3 eq. POCl3, 
reflux, 1 h, 81%
2 eq. NaBH4, MeOH, 






Scheme 3.25: Synthesis of 1-benzyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (125). 
 
The amine 36 was acylated with 122 to give the amide 123 in 79% yield. The structure of 
123 was evident from the 1H NMR spectrum showing a singlet for the benzylic methylene 
group at δH 3.53 and two singlets for the methoxy groups at δH 3.82 and δH 3.85. The 
carbonyl signal was not observed in the 13C NMR, which may be attributed to a “keto-
enol” equilibrium of the amide. However the IR spectrum showed a carbonyl stretch at 
1673 cm-1. The amide was then refluxed in excess POCl3 and gave the 
dihydroisoquinoline 124 in 81% yield. The dihydroisoquinoline 124 was reduced with 
NaBH4 at 0 ºC to give the tetrahydroisoquinoline 125 in 76% yield.  
The structure of 125 was confirmed by the 1H NMR, 13C NMR, MS and IR spectra. The 
1H NMR spectrum showed distinctive signals at δH 6.34 and δH 6.51 for H-8 and H-5, 
respectively; the signal for H-6 had disappeared showing that the ring had closed at C-6. 
The 13C NMR showed the signal for the benzylic carbon at δC 42.2 and a signal C-1 at δC 























Sat. NaHCO3, DCM:H2O (1:1), 
rt, 12 h, 91%









2 eq. NaBH4, MeOH, 
0 oC, 2 h, 48%
 
Scheme 3.26: Synthesis of 6,7-dimethoxy-1-(4-methoxybenzyl)-1,2,3,4-
tetrahydroisoquinoline (129). 
 
The commercially available p-methoxyphenylacetic acid was converted to the acid 
chloride 126 and further used to acylate the amine 36 using the procedure in Scheme 
3.25. The THIQ 129 was obtained in 48% yield and the 1H NMR spectrum showed three 
methoxy singlets at δH 3.89, δH 3.93 and δH 3.94. Comparing to the C-4' signal from that 
of 125 with that of  129, a noticeable chemical shift was observed, it shifted from δC 129.6 
in 121 to δC 167.1 in 129 due to the strong electron-withdrawing effect of the methoxy 
group in the C-4′ position. The MS showed m/z of 314.1759.  
3.7.6 Preparation of 1-Ethyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (133) 
Compound 133 was synthesized in 51% yield (based on the amide, 131) from 3,4-
dimethoxyphenylethylamine (36) and propanoyl chloride (130). The amide (131) was 
obtained as a yellow solid in 91% yield with a melting point of 125.7 ºC. Bischler-
Napieralski cyclisation of 131 followed by reduction of 132 afforded the desired product 
133 as a brown oil. In agreement with the structure, a methyl signal was observed at δH 
1.09, a multiplet for the four methylene protons at δH 2.80-3.40 and the two aromatic 
protons at δH 6.59. The MS showed m/z 222.1501 and the IR showed the methyl stretch at 










Sat. NaHCO3, DCM:H2O (1:1), 
rt, 12 h, 91%












2 eq. NaBH4, MeOH, 
0oC, 2 h, 67%
132133
 
Scheme 3.27: Synthesis of 1-ethyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (133). 
 
3.7.7 Preparation of (R)-1-Benzyl-6,7-dimethoxy-N-(1-phenylethyl)-1,2,3,4-
tetrahydroisoquinoline (R-136) 
Both the (R)- and (S)-enantiomers of α-methylbenzylamine (30) and (R)-(-)-1,2,3,4-
























Sat. NaHCO3, DCM:H2O (1:1), 
rt, 12 h, 89%
3 eq. POCl3,
reflux, 1 h
2 eq. NaBH4, MeOH, 












The amine (R-36) was acylated with phenylacetyl chloride (122) to give the chiral 
acetamide (R-134) in 83% yield. Treatment of R-134 with excess POCl3 allowed 
Bischler-Napieralski cyclisation and gave the dihydroisoquinolinium salt (R-135) that 
was used without purification. The hydride reduction of R-135 gave R-136 in 52% yield 
based on the amide. The product R-136 gave an optical rotation of [ ] 	= +61.6° (1.4, 
CHCl3). The structure of the product R-136 was in consistent with the NMR and the MS 
data. The 1H NMR spectrum showed twelve aromatic protons compared to the thirteen 
aromatic protons found 134. The signal at δC 68.1 was assigned to C-1 and was in good 
agreement with the previously reported value.2,3 The MS found m/z 388.2285 for 
C26H30NO2 which is also consistent with the structure of (1R)-benzyl-6,7-dimethoxy-N-
(1R-phenylethyl)-1,2,3,4-tetrahydroisoquinoline (R-136). 
 
























Sat. NaHCO3, DCM:H2O (1:1), 
rt, 12 h, 91%
3 eq. POCl3,
 reflux, 1 h
2 eq. NaBH4, MeOH,  






Scheme 3.29: Synthesis (S)-1-benzyl-6,7-dimethoxy-N-(1-phenylethyl)-1,2,3,4-
tetrahydroisoquinoline (S-136). 
 
Using the same procedure as in Scheme 3.26, S-136 was synthesized in 51% yield, the 
spectral data of R-136 and S-136 being in good agreement. The NMR data of the chiral 





cyclisation of S-134 afforded a single enantiomer S-136 in a moderate yield. The optical 
rotation of S-136 was in opposite direction to that of R-136 and was measured to be [ ] 	= 
-83.7° (1.6, CHCl3).  
 
3.7.9 Preparation of 1-Benzyl-6,7-dimethoxy-2-(1,2,3,4-tetrahydro-1-
naphthalenyl)-1,2,3,4-tetrahydroisoquinoline (139) 
Using the same procedure as in Scheme 3.27, the synthesis of 139 was attempted with no 
success. Since the amount of the starting material 137 was enough to explore different 
reaction conditions, various factors that could affect the reaction were changed. The 
reflux period for the Bischler-Napieralski cyclisation was increase from 1 h to 12 h but 
there was no change. The NMR showed multiple products with no peaks that were 











Sat. NaHCO3, DCM:H2O (1:1), 
rt, 12 h, 96%
3 eq. POCl3,
 reflux, 1 h
2 eq. NaBH4, MeOH, 














Scheme 3.30: Attempted synthesis of 1-benzyl-6,7-dimethoxy-2-(1,2,3,4-tetrahydro-1-
naphthalenyl)-1,2,3,4-tetrahydroisoquinoline (139). 
 
3.7.10 Stereochemical Analysis 
It has been verified by several researchers that the stereochemical outcome of the product 
is the Bischler-Napieralski reaction is the same as that of the chiral auxiliary starting 





136 and S-136 was going to be R and S, respectively. The intergrals of the methoxy 
signals in the 1H NMR data shows one diastereomer for each of the product with 96% and 
90% de for R-136 and S-136 respectively. 
Since the reactivity of the imines is similar to that of carbonyls, the reaction mechanism 
can be explained by the Burgi’s30 model which explains the reactivity of carbonyls 
toward nucleophiles. The nucleophilic approach towards the C=N carbon atom pushes the 
alkyl substituents away thus stretching the C=N distance. The nucleophile approaches 























Scheme 3.31: Mechanism for diastereoselective Bischler-Napieralski reaction. 
 
The stereoselective reduction of the C=N bond of the chiral iminium (135) ion is a 
powerful synthetic tool for the formation of THIQ’s with high diastereomeric excess. 
Scheme 3.30 provides a mechanistic explanation for the diastereoselectivity that occurs in 
the Bischler-Napieralski reaction. Between R-136a and R-136b, the more stable 
conformation is R-136b and it allows the nucleophilic attack at the Si face therefore 






Table 3.1: Summary of THIQ’s synthesized. 









3.8 Conclusion and Recommendations 
Stereoselective and non-stereoselective synthesis of THIQ’s has been achieved by using the 
Bischler-Napieralski reaction. Chiral auxiliaries were employed to control the 
stereochemical outcome of the enantiopure THIQ’s. The first attempt using the Pictet-
Spengler reaction failed due to the lack of reactivity of the phenylacetaldehyde (79). This 
was not in accordance with the previously reported results in our laboratory. Three different 
chiral auxiliaries were employed for the synthesis of enantiomerically pure THIQ’s.  Both 
(R) and (S)-(α)-methylbenzylamine gave good results but (R)-(-)-1,2,3,4-tetrahydro-1-
naphthylamine failed  to give a product. This reaction requires further investigation.  
The employed synthetic route is straight forward, shorter than the traditional method for the 
synthesis of THIQ’s that has been previously used this research group. It is believed that 
this method will be of general applicability for the synthesis of similar classes of 
compounds. Various challenges encountered during the synthesis were overcome by 
exploring different reaction conditions and it revealed the need for more research that needs 
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4.1 General Experimental Procedure 
All reagents were purchased from Aldrich or Merck and used without further purification. 
Hexanes for chromatographic separation were purified by distillation at 70 °C before use. 
Anhydrous solvents were obtainable from a Technologies (Newburyport, MA) Pure-Solv. 
800 solvent purification system. All reactions requiring anhydrous conditions were 
performed under an atmosphere of nitrogen using oven-dried glassware.  
Analytical thin-layer chromatography (TLC) was performed on aluminium plates covered 
with silica gel 60 F254 (0.25 mm thickness) and precoated with a fluorescent indicator. 
The developed plates were visualized under UV light (254 nm) and stained with 
anisaldehyde stain (0.5 mL p-anisaldehyde in 85 mL of MeOH containing 4 mL of H2SO4 
and 10 mL glacial acetic acid) or Drangendorff’s reagent [(Solution A: bismuth nitrate 
(0.85 g) was dissolved in a mixture of  acetic acid (10.0 mL) and distilled water (40.0 
mL). Solution B: KI (8.00 g) was dissolved in distilled water (20.0 mL). 5.00 mL of each 
of the solutions were mixed, acetic acid was added to the solution (20.0 mL) and made up 
to 100 mL using distilled water)].  
 
Flash chromatography was performed by employing Merck Kielselgel 60 (230-400 mesh) 
in a glass column with diameter 25 mm or 40 mm with a fritted disc (porosity C). A 
Chromatotron (model 7924, Harrison Research) was used for centrifugal 
chromatography. The plates for the Chromatotron (1 mm, 2 mm and 4 mm) were 
prepared using silica gel 60 PF254 (containing gypsum) for preparative chromatography. 
 
All 1H NMR, 13C NMR and 31P NMR spectra were recorded using Bruker DXR-400 and 
500 spectrometers at 25 °C. The signal multiplicities were abbreviated as shown below and 








Abbreviations used in 1H NMR spectrum signal multiplicities: 
s singlet  t triplet 
brs broad singlet q quartet  
d doublet m multiplet 
dd doublet of doublets 
 
Table 4.1: 1H and 13C NMR solvent Chemical shifts 
Solvent 1H Chemical Shift (δH) 13C Chemical Shift (δC)   
CDCl3 7.26 77.0 
DMSO-d6 2.50 39.5 
 
Infrared spectra were obtained on a Bruker Alpha IR spectrometer and optical rotation was 
measured using a Bellingham & Stanley Ltd polarimeter (ADP440+) with a cuvette of 1 cm 
path length. Melting points of recrystallized material were measured using a Reichert 
electrothermal melting point apparatus. All high-resolution mass spectroscopic (HRMS) 
data were collected on a TOF Waters LCT Premier mass spectrometer using electrospray 
ionization in the positive or negative mode with nitrogen as a carrier gas.   
 
4.2 Synthetic Methods 






A mixture of 3,4-dihydroxybenzaldehyde (89) (2.00 g, 14.5 mmol), K2CO3, (4.56 mg, 33 
mmol) and MeI (2.1 mL, 21.7 mmol) in anhydrous acetone (10 mL) was stirred vigorously 





order to destroy unreacted Me2SO4. The aqueous layer was extracted with EtOAc (2 x 30 
mL) and acidified with HCl (30 mL, 1 M).  The combined EtOAc layers were washed with 
water and brine, dried over MgSO4 and concentrated under vacuum. The product was 
purified by column chromatography (hexanes-EtOAc, 9:1) to give 61 (98.1 mg, 45%) as a 
yellow oily product. 
Method B 
A mixture of vanillin (90) (200 mg, 1.31 mmol), K2CO3, (456 mg, 3.3 mmol) and Me2SO4 
(0.19 mL, 2.0 mmol) in anhydrous acetone (10 mL) was stirred vigorously at 60 °C under 
reflux overnight.  Excess NH4OH (1 M) was added to the reaction mixture in order to 
destroy the unreacted Me2SO4. The aqueous layer was extracted with EtOAc (2 x 30 mL), 
the combined EtOAc layers were washed with water and brine, dried over MgSO4 and 
concentrated on a rotary evaporator. The product was purified using centrifugal 
chromatography (hexanes-EtOAc, 9:1) to afford 3,4-dimethoxybenzaldehyde (61, 115 mg, 
53%) as a yellow oil. 
Method C 
To a solution of vanillin (90) (5.00 g, 32.8 mmol), K2CO3 (11.36 g, 82.2 mmol) in dry 
acetonitrile (40.0 mL), Me2SO4 (4.67 mL, 49.3 mmol) was added. The reaction mixture was 
stirred at 60 °C for 12 h. Excess Me2SO4 was destroyed by adding a solution of NH4OH (1 
M) after cooling the reaction mixture to room temperature. The resulting mixture was 
extracted with Et2O (3 x 30 mL), washed with brine, dried over MgSO4 and finally 
concentrated under vacuum. The product was obtained as a yellow oil in (5.08 g, 93%) 
yield.  
1H NMR (CDCl3): δH 3.95 (3H, s, OCH3), 3.97 (3H, s, OCH3), 7.00 (1H, d, J = 8.3 Hz, H-
5), 7.42 (1H, d, J = 1.9 Hz, H-2), 7.46 (1H, dd, J = 8.3 Hz, 1.9 Hz, H-6), 9.86 (1H, s, 
CHO). 
13C NMR (CDCl3): δC 56.0 (OCH3), 56.2 (OCH3), 109.1 (C-2), 110.4 (C-5), 126.8 (C-6), 
130.2 (C-1), 149.7 (C-3), 154.6 (C-4), 191.0 (CHO).  
HR-ESI-MS (positive ionization mode), m/z found 189.1632 [M+Na]+; calculated for 
C9H10NaO3 189.1639. 





4.2.2 1,2-Dimethoxy-4-(-2-methoxyvinyl)benzene (92) 
OMeMeO
MeO  
A mixture of (methoxymethyl)triphenylphosphonium chloride (4.53 g, 13.2 mmol), t-
BuOK (1.35 g, 12.0 mmol) in dry THF (15 mL) was stirred at 0 °C for 10 min. 3,4-
Dimethoxybenzaldehyde (61) (1.00 g, 13.2 mmol) was added and the mixture stirred for 6 h 
at room temperature. The reaction mixture was diluted with water and the aqueous layer 
was extracted with Et2O (2 x 20 mL). The combined Et2O layers were washed with water 
and brine and dried over a rotary evaporator. Purification by column chromatography 
(hexanes- EtOAc, 9:1) gave the enol ether 92 as a mixture of the cis and trans isomers (0.49 
g, 42%) as a yellow oil. 
1H NMR (CDCl3): δH 3.66 (3H, s, OCH3), 3.76 (3H, s, OCH3), 3.85 (3H, s, OCH3), 3.86 
(3H, s, OCH3), 3.87 (6H, s, 2 x OCH3), 5.16 (1H, d, J = 7.1 Hz, CHCHOCH3 cis), 5.77 
(1H, d, J = 12.9 Hz, CHCHOCH3 trans); 6.06 (1H, d, J = 7.1 Hz cis-CHCHOCH3); 6.75 - 
6.81 (4H, m, 1H, belongs to cis system (H-5), 3H belongs to H-5, H-6 & H-2 belongs to the 
trans system, 6.93 (1H, d, J = 12.9 Hz, trans-CHCHOCH3), 7.06 (1H, dd, J = 8.6 Hz, 1.8 
Hz, H-6 cis), 7.24 (1H, d, J = 1.8 Hz, H-2, cis). 
13C NMR (CDCl3): δC 55.7 (OCH3), 55.8 (OCH3), 55.8 (OCH3), 55.9 (OCH3), 56.5 
(OCH3), 60.5 (OCH3), 104.9 (CHCHOCH3 trans), 105.5 (CHCHOCH3 cis), 108.4 (C-2 
trans), 111.0 (C-2, C-5 ), 111.7 (C-2 cis), 117.6 (C-6 cis), 120.9 (C-6 trans), 129.1 (C-1 
cis), 129.4 (C-1 trans), 146.5 5 (CHCHOCH3 cis), 147.2 (C-4 trans), 147.4 (C-4 cis), 
147.75 (CHCHOCH3 trans), 148.5(C-3 trans),   149.1 (C-3 cis). 
HR-ESI-MS (positive ionization mode), m/z found 217.0842 [M+Na]+; calculated for 
C11H14NaO3 217.0841. 
IR: νmax (neat)/ cm-1 1236, 1462, 1732. 
 










To a solution of 92 (100 mg, 0.59 mmol) in dry THF (10 mL), H2SO4 (6 M, 0.10 mL) was 
added in a dropwise manner. The reaction mixture was allowed to stir at room temperature 
for 1 h. To reaction mixture, saturated aq. NaHCO3 solution (5 mL) was then added 
dropwise and the organic layer extracted with EtOAc (3 x 10 mL). The combined EtOAc 
layers were combined, washed with brine and dried over anhydrous MgSO4 and 
concentrated under vacuum. The product 79 was observed in the 1H NMR spectrum with a 
number of impurities.  
Method B 
To a solution of 92 (100 mg, 0.6 mmol) in dry THF (10 mL), H2SO4 (0.1 mL, 6 M) was 
added in a dropwise manner followed by the addition of a spatula tip of SiOCl2 catalyst. 
The reaction mixture was allowed to stir at room temperature for 1 h. The reaction was 
quenched by dropwise addition of -saturated aq. NaHCO3 solution (5 mL) and extracted 
with EtOAc (3 x 10 mL). The organic layers were combined and washed with brine and 
dried over MgSO4. Multiple products were observed on the TLC plate showing 
decomposition of the phenylacetaldehyde (79).  
Method C 
FeCl3.6H2O (0.27 mg, 1 mmol) was stirred in EtOAc-H2O (1:1) at room temperature for 30 
min. TEMPO (100 mg, 0.1 mmol), was added and stirred for 15 min. 2-(3,4-
Dimethoxyphenyl)ethanol (96) (100 mg, 0.27 mmol) dissolved in EtOAc-H2O (1:1) was 
added in a dropwise manner. The reaction mixture was allowed to stir at room temperature 
for 6 h. The organic layer was extracted using EtOAc, washed with water and brine and 
then dried over MgSO4 and concentrated under vacuum. In the 1H NMR spectrum of the 
crude mixture no product was observed.  
Method D 
A solution of oxalyl chloride (0.5 mL, 0.5 mmol) at -78 °C, DMSO (0.72 mL) was added in 
a dropwise manner. The reaction mixture was stirred for 15 min. 2-(3,4-
dimethoxyphenyl)ethanol (96) (100 mg, 0.5 mmol) in DCM was added slowly over a 
period of 5 minutes. The stirring was continued for 1 h at -78 °C. Et3N (0.38 mL, 2.7 





78 °C.  The reaction mixture was allowed to warm to room temperature and the resulting 
yellow mixture was diluted with water. The organic layer was extracted with DCM (2 x 10 
mL) and dried over MgSO4 and concentrated under vacuum at room temperature to avoid 
decomposition. The crude product 79 was used without further purification in order to 
avoid decomposition.  
Method E 
IBX (105) (114 mg, 0.4 mmol) was dissolved in DMSO (3 mL) over 15 min while stirring 
at room temperature. 2-(3,4-dimethoxyphenyl)ethanol (96) (62.0 mg, 0.3 mmol) dissolved 
in DMSO was added in a dropwise manner at room temperature. The reaction mixture was 
allowed to stir for a further 5 h at room temperature. The reaction was quenched with water. 
The organic layer was extracted with EtOAc (3 x 10 mL) dried over MgSO4 and 
concentrated under vacuum. Purification was carried on silica column chromatography 
(hexanes-EtOAc, 7:3). Traces of the product 79 were observed in the 1H NMR spectrum.   
1H NMR (CDCl3): δH 3.62 (2H, d, J = 2.5 Hz CH2CHO,), 3.88 (6H, s, 2 x OCH3), 6.71 
(1H, d, J = 2.1 Hz, H-2); 6.77 (1H, dd, J = 2.1, 8.0 Hz, H-6), 6.87 (1H, d, J = 8.0 Hz, H-
5), 9.73 (1H, t, J = 2.4, CHO). 
13C NMR (CDCl3): δC 50.1 (CHOCH2), 55.9 (OCH3), 55.9 (OCH3), 111.7 (C-2), 112.7 
(C-5), 122.0 (C-6), 124.3 (C-1), 148.5 (C-4), 149.4 (C-3), 199.5 (CHO). 
 
4.2.4 1,2-Dimethoxy-4-vinylbenzene (95)  
MeO
MeO  
n-Butyllithium (2.4 mL, 3.7 mmol) was added at 0 °C to a suspension of 
methyltriphenylphosphonium iodide (3.00 g, 7.4 mmol) in dry THF (15 mL) and stirred for 
20 min followed by dropwise addition of 3,4-dimethoxybenzaldehyde (61) (2.00 g, 1.9 
mmol) in dry THF over 15 min. The reaction mixture was stirred at room temperature for 5 
h. The reaction mixture was diluted with water and extracted with Et2O (3 x 30 mL). The 
combined ether layers were washed with water, brine, dried over MgSO4 and evaporated to 
dryness under vacuum. Purification by chromatography (hexanes-EtOAc, 9:1) gave 95 





1H NMR (CDCl3): δH 3.88 (3H, s, OCH3), 3.91 (3H, s, OCH3), 5.15 (1H, d, J = 10.9 Hz, 
CHCH2, cis), 5.61 (1H, J = 17.8 Hz, CHCH2, trans), 6.68 (1H, dd, J = 10.8, 17.8 Hz, 
CHCH2), 6.82 (1H, d, J = 8.2 Hz, H-5), 6.93 (1H, dd, J = 2.0, 8.2 Hz, H-6), 6.96 (1H, d, J = 
2.0 Hz, H-2). 
13C NMR (CDCl3): δC 55.8 (OCH3), 55.9 (OCH3), 108.6 (CHCH2), 111.1 (C-2), 111.7 (C-
5), 119.4 (C-6), 130.8 (C-1), 136.5 (CHCH2), 149.0 (C-3), 149.1 (C-4). 
HR-ESI-MS (positive ionization mode), m/z found 165.0915 [M+H]+; calculated for 
C10H13O2 165.0916.  
IR: νmax (neat)/ cm-11261, 1462, 1642. 
 
4.2.5 2-(3,4-Dimethoxyphenyl)ethanol (96) 
OHMeO
MeO  
To a solution 3,4-dimethoxyvinylbenzene (95) (1.50 g, 9.1 mmol) in dry THF (15 mL), 
BH3.S(CH3)2 (1.30 mL, 1.37 mmol) was added dropwise. The reaction mixture was stirred 
at room temperature for 6 h then cooled to 0 ºC for 10 min. A cold solution (0 ºC) of NaOH 
(20 mL, 3 M) was added, followed by H2O2 (0.55 mL, 1.8 mmol).  The reaction mixture 
was allowed to stir overnight at room temperature. The reaction mixture was then extracted 
with Et2O (3 x 20 mL) and the organic layer was washed with water and brine, dried over 
MgSO4 and the solvent was removed under vacuum. The resulting crude product was 
purified by radial chromatography (hexanes-EtOAc, 3:2) to give 96 as a colourless oil (0.55 
g, 33%). 
1H NMR (CDCl3): δH 2.82 (2H, t, J = 6.5 Hz, CH2CH2OH), 3.83 – 3.88 (8H, m, 2 x OCH3, 
CH2CH2OH), 6.77 (2H, m, H-2 & H-6), 6.83 (1H, d, J = 8.5 Hz, H-5). 
13C NMR (CDCl3): δC 38.8 (CH2CH2OH), 55.9 (CH3O), 59.9 (CH3O), 63.8 (CH2CH2OH), 
111.6 (C-2), 112.4 (C-5), 121.0 (C-6), 131.1 (C-1), 147.9 (C-4), 149.1 (C-3). 






IR: νmax (neat)/ cm-11232, 1590, 3381. 









To a solution of 2-(3,4-dimethoxyphenyl)ethanol (96) (1.01 g, 5.5 mmol) at 0 ºC in dry 
DCM (3.00 mL), triethylamine (0.67 mL, 0.7 mmol) was added slowly followed by tosyl 
chloride (1.57 g, 8.2 mmol). The reaction mixture was stirred at room temperature for 30 
min, diluted with DCM and then treated with a saturated aq. NaHCO3 solution. The organic 
layer was extracted with DCM, washed with brine, dried over MgSO4 and concentrated 
under vacuum.1-3 The crude mixture was purified by column chromatography (hexanes-
EtOAc, 3:2) and the product 117 was obtained as a light-yellow oil (0.68 g, 37%). 
1H NMR (CDCl3): δH 2.42 (3H, s, CH3-Ph), 2.89 (2H, t, J = 7.2 Hz, CH2CH2O), 3.80 (3H, 
s, OCH3), 3.85 (3H, s, OCH3), 4.20 (2H, t, J = 7.3 Hz, CH2CH2O), 6.60 (1H, d, J = 2.0 Hz, 
H-2), 6.65 (1H, dd, J = 2.0, 8.4 Hz, H-6), 6.74 (1H, d, J = 8.1 Hz, H-5), 7.28 (2H, d, J = 6.2 
Hz, Ph), 7.67 (2H, d, J = 8.1 Hz, Ph).  
13C NMR (CDCl3): δC 21.6 (CH3-Ar), 35.0 (CH2CH2O), 55.8 (CH3O) 55.9 (CH3O), 70.8 
(CH2CH2O), 111.3 (C-2), 112.1 (C-5), 121.0 (C-6), 127.8 (C-Ar),128.7 (C - Ar),129.8 (C-
1), 133.0 (C1-Ar), 148.1 (C-4), 148.9 (C-5).  
HR-ESI-MS (positive ionization mode), m/z found 359.0934 [M+Na]+; calculated for 
C17H20NaO5S 359.0929. 












Phenylactetaldehyde (108) (0.1 mL, 0.8 mmol) in dry THF (10 mL) was refluxed at 60 °C 
for 10 min followed by the dropwise addition of (S)-(α)-methylbenzylamine (S-30) (0.1 
mL, 83 mmol) and the reaction mixture was allowed to stir overnight. Afterwards the 
reaction mixture was cooled down to 0 ºC and the solution of NaBH4 (126 mg, 3.3 mmol) 
in methanol was added slowly over 15 min. The reaction was quenched by the addition of 
saturated aq. NaHCO3 (5 mL). The mixture was extracted with EtOAc, the organic layer 
washed with water and brine, dried over MgSO4 and evaporated to dryness. 
Chromatographic purification (hexanes-EtOAc, 1:1) yielded only the two starting materials. 
Method B 
To a solution of 108 (100 mg, 0.6 mmol) in dry THF (10 mL), (S)-(α)-methylbenzylamine 
(0.11 mL, 8.3 mmol) was added dropwise. The reaction mixture was allowed to stir 
overnight and then Na(CH3COO)3BH (0.165 g, 0.8mmol) was added to the reaction 
mixture and then allowed to stir for further 3 h. The mixture was not purified since no 
major product was observed.  
Method C 
A spatula tip of silica chloride was added to a stirred mixture of 108 (1.0 mL, 8.32 mmol) 
and (S)-(α)-methylbenzylamine (1.1 mL, 8.32 mmol) in dry THF (10 mL). NaBH4 (1.02 g, 
33.3 mmol) dissolved in MeOH (5 mL) was added dropwise at room temperature. The 
reaction mixture was allowed to stir at room temperature overnight. The reaction mixture 
was diluted with aqueous NaHCO3. The mixture was extracted with Et2O (3 x 15 mL), the 
organic layers were washed with water and brine, dried over anhydrous MgSO4 and 
evaporated to dryness. The residue was purified by chromatography (hexanes-EtOAc, 1:1) 
to yield the product 109 as a yellow oil (0.7 g, 37% yield).  





1H NMR (CDCl3): δH 1.41 (3H, d, J = 6.8 Hz, CHCH3), 2.79-2.90 (4H, m, CH2CH2NH), 
3.86 (1H, q, J = 6.6 Hz, CHCH3), 7.27-7.42 (10H, m, Ph). 
13C NMR (CDCl3): δC 24.1 (CH3), 36.3 (CH2CH2NH), 48.8 (CH2CH2NH), 58.1 
((CHCH3), 126.0 – 128.9 (C-Ar), 140.0 (C-Ph), 145.4 (C-1). 
HR-ESI-MS (positive ionization mode): m/z found 226.1593 [M+H]+; calculated for 
C16H20N 226.1596. 
IR: νmax (neat)/ cm-1 1028, 1182, 2925. 
 







To a solution of 3,4-dimethoxyphenylacetaldehyde (79) in dry THF (10 mL), (R)-(α)-
methylbenzylamine (0.11 mL, 8.3 mmol) was added in a dropwise manner. The reaction 
mixture was stirred for 3 h, after which saturated aq. NaHCO3 solution was added. The 
mixture was extracted using EtOAc (3 x 10 mL), the organic layer dried over MgSO4 and 
concentrated under vacuum. The crude product was subjected to chromatography (hexanes-
EtOAc, 3:2) but no major product was isolated.  
Method B 
To a stirred solution of 3,4-dimethoxyphenylacetic acid (100 mg, 0.4 mmol) in MeOH-
H2O, 10:1 (10 mL) at -15 °C, isobutyl chloroformate (0.05 mL, 0.38 mmol) was added 
followed by the addition of Et3N (0.05 mL, 0.4 mmol). The reaction mixture was allowed to 
stir for 1 h and then (R)-(α)-methylbenzylamine was added dropwise (0.07 mL, 0.6 mmol). 
The reaction mixture was stirred overnight. Multiple products were formed which were 








A solution of 2-(3,4-dimethoxyphenyl)ethyl 4-methylbenzenesulfonate (117) (1.50 g, 
1.49 mmol) in dry THF (15 mL) was added dropwise to a stirring solution of (R)-(α)-
methylbenzylamine (0.29 mL, 2.2 mmol) in dry THF (1 mL) at room temperature. The 
reaction mixture was refluxed for 12 h. The crude mixture was purified by column 
chromatography (DCM-EtOAc, 1:1). The product R-31 was obtained as a yellow oil (61 
mg, 48%). 
 [ ]  = + 43.2 (1.4, CHCl3). 
1H NMR (CDCl3): δH 1.35 (3H, d, J = 6.7 Hz, NHCHCH3Ph), 1.82 (1H, brs, NH)  2.67 – 
2.79 (4H, m, PhCH2CH2), 3.75 – 3.80 (1H, m, NHCHCH3Ph), 3.83 (3H, s, OCH3), 3.85 
(3H, s, OCH3), 6.67 (1H, d, 1.8 Hz, H-2) , 6.70 (1H, dd, J = 1.9; 8.0 Hz, H-6), 6.78 (1H, 
d, J = 8.1-H-5), 7.20 – 7.32 (5H, m, Ph). 
13C NMR (CDCl3): δC 24.1 (NHCHCH3Ph), 35.8 (RCH2CH2NHR), 48.9 
(RCH2CH2NHR), 55.8 (OCH3), 55.9 (OCH3), 58.2 (RCH2CH2NHR), 111.4 (C-5), 112.0 
(C-2), 120.6 (C-6), 126.6-128.4 (Ar), 132.6 (C1-Ph), 145.3 (C-3), 147.5 (C-1), 148.9 (C-
4). 
 
HR-ESI-MS (positive ionization mode), m/z found 308.1633 [M+Na]+; calculated for 
C18H23NaNO2 308.1626. 
IR: νmax (neat)/ cm-11028, 1236, 2930. 
 







A solution of the tosylate (117) (1.35 g, 1.34 mmol) in dry THF (15 mL) was added 
dropwise to a stirring solution of (S)-(α)-methylbenzylamine (S-30) (0.26 mL, 2.0 mmol) 
in dry THF (1 mL) at room temperature. The reaction mixture was allowed to reflux at 90 





1:1). The product S-31 was obtained as a yellow oil (57 mg, 45%). The spectral data was 
in good agreement with previously synthesized R-31. 
 







To a stirring solution of the tosylate (117) (64 mg, 0.2 mmol) in dry THF (10 mL) and (R)-
(-)-1,2,3,4-tetrahydro-1-naphthylamine (0.14 mL, 0.1 mmol) in dry THF (1 mL). The 
reaction mixture was refluxed at 90 °C overnight and then cooled to room temperature. A 
saturated aq. NaHCO3 solution (15 mL) was added and the organic layer was extracted with 
EtOAc (3 x 15 ml). The combined organic layers were dried over MgSO4 and the solvent 
was removed in a rotary evaporator. The crude mixture was purified in the Centrifugal 
chromatography (DCM-EtOAc, 1:1). The product 119 was isolated as an orange oil (25 mg, 
42%).  
[ ] 	= -45.3 (1.1, CHCl3). 
1H NMR (CDCl3): δH 1.74 (4H, m, NHCHCH2CH2), 2.03 (1H, brs, NH), 2.81 (2H, m, 
CH2CH2NH), 2.91 - 3.01 (4H, m, CH2NH & CH2Ph), 3.85 (3H, s, OMe), 3.85 (3H, s, 
OMe), 4.05 (1H, s, NHCH), 6.73 - 6.80 (3H, m, H-5, H-6 & H-2), 7.06-7.15 (4H, m, Ph). 
13C NMR (CDCl3): δC 19.3 (CH2CH2Ph), 26.2 (CHCH2CH2), 28.9 (CH2CH2Ph), 29.8 
(CH2CH2NH), 55.5 (CHNHCHCH2), 56.8 (2 x OCH3), 111.4 (C-2), 112.2 (C-5), 120.8 (C-
6), 126.3 - 138.5 (C-Ar), 147.9 (C-4), 149.1 (C-3).   
HR-ESI-MS (positive ionization mode), m/z found 312.1974 [M+H]+; calculated for 
C20H26NO2 312.1964. 












To a solution of freshly distilled 2-(3,4-dimethoxyphenyl)ethylamine (36) (0.10 mL, 0.60 
mmol) in DCM (5 mL) containing a small quantity of p-toluenesulfonic acid and 3Å 
molecular sieves, freshly distilled p-anisaldehyde  (120) (0.07 mL, 0.6 mmol) was added 
dropwise. The reaction mixture was stirred at room temperature for 24 h. The solution was 
diluted with DCM and filtered, followed by concentration under vacuum. The resulting 
slurry was then dissolved and refluxed in TFA (3 mL) for 4 h under a nitrogen atmosphere. 
The resulting solution was then poured into ice and basified with saturated aq. NaHCO3. 
The organic layer was extracted with DCM, washed with brine and dried under vacuum. 
The crude mixture was separated using EtOAc-MeOH (5:2) by centrifugal chromatography. 
The fractions were evaluated on TLC plates stained with Dragendorff’s reagent. The 
product was isolated (55 mg, 40%) as a yellow oil. 
1H NMR (CDCl3): δH 3.04 (4H, m, CH2CH2NH), 3.61(3H, s, OCH3), 3.75 (3H, s, OCH3), 
3.81 (1H, d, J = 3.1 Hz, H-1), 3.85 (3H, s, OCH3), 5.18 (1H, s, H-8), 6.61 (1H, s, H-5), 6.83 
(2H, d, J = 8.5 Hz, H-2′ & H-6′), 7.16 (2H, d, J = 8.5 Hz, H-3′ & H-5'). 
13C NMR (CDCl3): δC 30.8 (CH2CH2NH), 40.4 (CH2CH2NH), 55.2 (p-OCH3), 55.8 (2 x 
OCH3), 59.6 (C-1), 110.7 (C-8), 116.2 (C-3′ & C-5′), 114.0 (C-2′ & C-6′), 128.9 (C-4a), 
126.4 (C8-a), 130.7 (C-3′ or C-5′), 132.3 (C-1′), 147.6 (C-6), 148.4, (C-7), 159.6 (C-4′).  
HR-ESI-MS (positive ionization mode), m/z found 300.1605 [M+H]+; calculated for 
C18H22NO3 300.1600.  
 











To a solution of freshly distilled 2-(3,4-dimethoxyphenyl)ethylamine (36) (0.11 mL, 0.60 
mmol) in pyridine (5 mL) or saturated aq. Na2CO3 - DCM mixture, (1:1, 6 mL),  
phenylacetyl chloride (122) (0.07 ml, 0.6 mmol) was added and the reaction was stirred at 
room temperature overnight.4,5 The organic layer was extracted with DCM (3 x 10 mL) and 
washed with water and brine. Evaporation of the solvent gave a pale yellow crystalline 
product, found to be pure N-[2-(3,4-dimethoxyphenyl)ethyl]-2-phenylacetamide (123) (140 
mg, 79%).  
1H NMR (CDCl3): δH 2.68 (2H, t, J = 7.1 Hz, CH2CH2NH), 3.43 (2H, q, J = 7.1Hz,  
CH2CH2NH), 3.53 (1H, s, CH2Ph), 3.82 (3H, s, OCH3), 3.85 (3H, s, OCH3), 3.57 (1H, brs, 
NH), 6.55 (1H, dd, J = 2.0, 8.2 Hz, H-B), 6.60 (1H, d, J = 2.0 Hz, H-A), 6.72 (1H, d, J = 
8.0 Hz, H-X), 7.16 (1H, d, J =2.0 Hz, Ph), 7.17 (1H, d, J =1.8 Hz, Ph), 7.30 (3H, m, Ph). 
13C NMR (CDCl3): δC 35.0 (CH2CH2NH), 40.7 (CH2CH2NH), 43.6 (CH2Ph), 55.8 (OCH3), 
55.9 (OCH3), 111.4 (C-X), 111.8 (C-A), 120.5 (C-B), 127.5 (C-4′), 129.0 (C5′ & C-3′), 
129.4 (C-6′ & C-2′), 131.1 (C-4a), 134.7 (C-1′), 147.7 (C-6), 149.1 (C-7), 207.0 (C=O). 
HR-ESI-MS (positive ionization mode), m/z found 300.1347 [M+H]+; calculated for 
C18H22NO3 300.1342. 
IR: νmax (neat)/ cm-1 1231, 1633, 3242.  
 









To a solution of N-[2-(3,4-dimethoxyphenyl)ethyl]-2-phenylacetamide (123) (120 mg, 0.52 
mmol) in DCM (10 mL) and containing 3Å molecular sieves,  excess POCl3 (0.15 mL, 1.6 
mmol) was added and the mixture was refluxed for 1 h under a nitrogen atmosphere. The 
reaction mixture was cooled to room temperature and then poured into ice. The reaction 
mixture was extracted with EtOAc, and the combined extracts washed with brine, dried 
(anhydrous MgSO4) and concentrated under vacuum. The crude mixture (122 mg, 81%) 
was used without further purification to avoid decomposition.  
1H NMR (CDCl3): δH 2.86 (2H, t, J = 7.8 Hz, CH2CH2NH, 3.78 (3H, s, OCH3), 3.95 (5H, 
m, CH2CH2NH, OCH3), 6.77 (1H, s, H-5), 6.94 (1H, s, H-8), 7.48 (2H, t, J = 7.8 Hz, H-3′ 






To a solution of 124 (100 mg, 0.36 mmol) in dry MeOH (5 mL), NaBH4 (27 mg, 0.7 mmol) 
solution in methanol was added dropwise at 0 °C. The reaction mixture was stirred at room 
temperature for 2 h. A few drops of HCl were added to destroy unreacted NaBH4. The 
reaction mixture was extracted with EtOAc (3 x 20 mL) and the combined organic layers 
were washed with water and brine then finally dried over MgSO4. The crude mixture was 
purified by centrifugal chromatography (EtOAc-MeOH, 5:2). The product 125 was 
obtained as a brown oil (76 mg, in 76%).  
1H NMR (CDCl3): δH 2.75 (2H, t, J = 5.6 Hz, H-4), 3.23-2.95 (4H, m, H-3, PhCH2), 3.62 
(3H, s, OCH3), 3.87 (3H, s, OCH3), 4.23 (1H, t, J = 6.9 Hz, H-1), 4.33 (1H, brs, NH), 6.34 
(1H, s, H-8), 6.51 (1H, s, H-5), 7.24-7.15 (5H, m, Ph). 
 13C NMR (CDCl3): δC 39.8 (C-3), 42.2 (CH2Ph), 55.8 (OCH3), 55.8 (OCH3), 56.3 (C-1), 
109.7 (C-8), 111.7 (C-5), 126.1 – 129.6 (Ph), 138.2 (C-1′), 147.0 (C-6), 147.9 (C-7). 
HR-ESI-MS (positive ionization mode), m/z found 284.1645 [M+H]+; calculated for 





IR: νmax (neat)/ cm-1 1512, 1652, 3459. 







4-Methoxyphenylacetic acid (0.27 g, 1.7 mmol) was refluxed in SOCl2 (2 mL, 10 mmol) for 
2 h followed by the removal of excess SOCl2 under vacuum. The freshly prepared acid 
chloride was reacted with 2(3,4-dimethoxyphenyl)ethylamine (0.2 mL, 1.1 mmol) 
according to the procedure described for (131). The product 127 was obtained as a yellow 
solid (0.32 g, 93%) yield.   
1H NMR (CDCl3): δH 2.67 (2H, t, J = 7.0 Hz, CH2CH2NH), 3.45 (2H, q, J = 7.0 Hz, 
CH2CH2NH), 3.47 (2H, s, CH2CO), 3.80 (3H, s, OCH3), 3.82 (3H, s, OCH3), 3.85 (3H, s, 
OCH3), 5.36 (1H, brs, NH), 6.54 (1H, dd, J = 2.3, 8.2 Hz, H-6), 6.60 (1H, d, J = 1.8 Hz, H-
5), 6.72 (1H, d, J = 8.0 Hz, H-2), 6.83 (2H, d, J = 8.5 Hz, Ph), 7.07 (2H, d, J = 8.7 Hz, Ph). 
13C NMR (CDCl3): δC 35.0 (CH2CH2NH), 40.7 (CH2CO), 42.9 (CH2CH2NH), 55.3 
(OCH3), 55.8 (OCH3), 55.9 (OCH3), 111.4 (C-2), 111.9 (C-5), 114.5 (2 x C-Ph), 120.6 (C-
Ph), 126.7 (C-1), 130.6 (2 x C-Ph), 131.1 (C-6), 147.7 (C-4), 149.1 (C-3), 158.9 (C-Ph), 
171.4 (CO). 
HR-ESI-MS (positive ionization mode), m/z found 352.1518 [M+Na]+; calculated for 
C19H23NaNO4  352.1521. 
IR: νmax (neat)/ cm-1 1648, 2932, 3314. 
 











The title compound was prepared by dissolving   127 (0.2 g, 0.6 mmol) in anhydrous 
MeCN (10 mL) containing 3Å molecular sieves. Excess POCl3 (0.16 mL, 1.8 mmol) was 
added and the reaction mixture was stirred for 1 h under a nitrogen atmosphere.  The 
reaction mixture was cooled to room temperature followed by the evaporation of MeCN 
and excess POCl3 in a rotary evaporator. The resulting crude mixture of the 
dihydroisoquinoline was dissolved in anhydrous MeOH (10 mL), followed by the addition 
of NaBH4 (68 mg, 1.8 mmol) solution in anhydrous MeOH (5 mL) and stirred for 2 h at 
room temperature in the presence of 3 Å molecular sieves.  The crude mixture was purified 
on the centrifugal chromatography (EtOAc-MeOH, 5:2). The product 129 was isolated as a 
brown oil (91 mg, in 48%). 
  
1H NMR (CDCl3): δH 2.30 (2H, t, J = 7.9 Hz, H-4), 2.75 – 2.80 (1H, m, NH), 3.24 – 3.38 
(4H, m, CH2Ph), 3.89 (4H, m, OCH3, and H-1), 3.93 (3H, s, OCH3), 3.94 (3H, s, OCH3), 
6.83 – 6.92 (4H, m, Ph), 7.55 (1H, d, J = 2.0 Hz, H-5), 7.70 (1H, dd, J = 1.9, 6.4 Hz, H-8). 
13C NMR (CDCl3): δC 22.7 (C-4), 29.7 (C-3), 31.9 (CH2Ph), 52.0 (OCH3), 55.8 (OCH3), 
55.9 (OCH3), 56.0 (C-1), 110.3 (C-5), 112.1 (C-8), 114.0 (C-3′ & C-4′), 122.7 (C-4b), 
123.6 (C-2′ & C-6′), 128.4 (C-4a), 130.0 (C-1′), 148.9 (C-4), 153.1 (C-3), 167.0 (C-4′). 
HR-ESI-MS (positive ionization mode), m/z found 314.1759 [M+H]+; calculated for 
C19H24NO3 314.1756. 
IR: νmax (neat)/ cm-1 3465, 1510, 2924. 
 





2(3,4-Dimethoxyphenyl)ethylamine (36)  (0.1 mL, 0.6 mmol) and propionyl chloride (0.05 
mL, 0.6 mmol) were stirred in  saturated Na2CO3 - DCM solution, (1:1, 6 mL) at room 





with water and brine, dried over MgSO4 and the solvent was removed a rotary evaporator. 
The product 131 was obtained as a yellow oil (120 mg, 91%).  
1H NMR (CDCl3): δH 1.11 (3H, t, J = 8.0 Hz, CH2CH3), 2.14 (2H, q, J = 7.6 Hz, CH2CH3),  
2.74 (2H, t, J = 7.1 Hz, CH2CH2NH), 3.47 (2H, q, J = 7.1 Hz, CH2CH2NH), 3.84 (6H, d, J 
= 6.7 Hz, 2 x OCH3), 5.55 (1H, brs, NH), 6.69 (2H, d, J = 6.7 Hz, H-6, H-2), 6.8 (1H, d, 8.8 
Hz, H-5). 
13C NMR (CDCl3): δC 9.9 (CH3CH2), 29.8 (CH2CH2NH), 35.3 (CH2NH), 40.7 (CH3CH2), 
55.9 (OCH3), 56.0 (OCH3), 111.3 (C-2), 111.9 (C-5), 120.6 (C-6), 131.4 (C-1), 147.6 (C-4), 
147.0 (C-3), 173.7 (CO). 
HR-ESI-MS (positive ionization mode), m/z found 260.1265 [M+Na]+; calculated for 
C13H19NaNO3 260.1263. 
IR: νmax (neat)/ cm-1 1637, 2967, 3295. 
 





The title compound was prepared by dissolving compound 131 (85 mg. 0.4 mmol) in 
anhydrous MeCN (10 mL) containing 3Å molecular sieves. Excess POCl3 (0.11 mL, 1.2 
mmol) was added and the reaction mixture was stirred for 1 h under a nitrogen atmosphere.  
The reaction mixture was cooled to room temperature followed by the evaporation of 
MeCN and excess POCl3. The resulting crude mixture of the dihydroisoquinoline (132) was 
dissolved in anhydrous MeOH (10 mL) in the presence of 3 Å molecular sieves and stirred 
for 2 h at room temperature.  The crude mixture was purified on the centrifugal 






1H NMR (CDCl3): δH 1.09 (3H, t, J = 7.4 Hz, CH2CH3), 1.25 (1H, m, NH), 1.94 (2H, m, 
CH2CH3), 2.80 – 3.40 (4H, m, CH2CH2NH), 3.85 (6H, 2 x s, 2 x OCH3), 4.11 (1H, m, H-1), 
6.59 (2H, H-5 & H-8). 
13C NMR (CDCl3): δC10.3 (CH3), 27.4 (CH2CH3), 28.3 (CH2CH2NH), 40.3 (CH2NH), 55.9 
(C-1), 56.0 (OCH3), 56.3 (OCH3), 109.3 (C-5), 111.7 (C-8), 125.7 (C-4b), 127.5 (C-4a), 
147.8 (C-6), 148.0 (C-7). 
HR-ESI-MS (positive ionization mode), m/z found 222.1501 [M+H]+; calculated for 
C13H20NO2 222.1494. 









A saturated aq. Na2CO3 - DCM mixture, (1:1, 6 mL) of R-36 (230 mg, 0.8 mmol) and 
phenylacetyl chloride (122) (0.8 mL, 0.8 mmol) was stirred at room temperature overnight. 
After cooling to room temperature, the mixture was extracted with DCM (3 x 10 mL), the 
combined extracts were washed with water and brine and dried with MgSO4 and evaporated 
on a rotary evaporator.  The product was obtained as a yellow oil (270 mg, 83%) whose 
NMR spectrum was similar to that of S-134.  
[ ] 	= -41.2 (1.8, CHCl3). 
1H NMR (CDCl3): δH 1.45 (3H, d, J = 7.0 Hz, CHCH3), 2.15 (1H, m, CH2CH2N), 2.30 (1H, 
m, CH2CH2N), 2.56 (1H, m, CH2CH2N), 2.74 (1H, m, CH2CH2N), 3.23 (2H, m, CH2CO), 
3.80 (3H, s, OCH3), 3.81 (3H, s, OCH3), 3.82 (2H, s, CH2CO), 5.20 (1H, q, J = 7.0 Hz, 





13C NMR (CDCl3): δC 17.8 (CHCH3), 34.3 (CH2CH2N), 36.7 (CH2CH2N), 45.5 (CH2CO), 
55.8 (OCH3), 55.9 (OCH3), 56.0 (CHCH3), 126.9-129.5 (C-Ar), 147.0 (C-4), 149.0 (C-3), 
171.3 (CO).  
HR-ESI-MS (positive ionization mode), m/z found 426.2030 [M+Na]+; calculated for 
C26H29NaNO3 426.2045. 







The title compound was synthesized by dissolving 134 (120 mg, 0.3 mmol) in anhydrous 
MeCN (10 mL) containing 3Å molecular sieves. Excess POCl3 (0.10 mL, 0.9 mmol) was 
added and the reaction mixture was stirred for 1 h under a nitrogen atmosphere.  The 
reaction mixture was cooled to room temperature followed by the evaporation of MeCN 
and excess POCl3. The resulting crude mixture of the dihydroisoquinolium salt (R-135) was 
dissolved in anhydrous MeOH (10 mL) containing 3 Å molecular sieves and a methanol 
solution of NaBH4 (34 mg, 0.9 mmol) was then added and stirred for 2 h at room 
temperature.  The crude mixture was purified on the centrifugal chromatography (EtOAc-
MeOH, 5:2). It was isolated as a brown oil (60.1 mg, in 52%). 
[ ] 	= +61.6 (1.4, CHCl3). 
1H NMR (CDCl3): δH 1.98 (1H, d, J = 7.8 Hz, CH(CH3)Ph), 2.30 - 2.35 (4H, m, 
CH2CH2N), 2.86 (2H, m, CHCH3), 3.86 (6H, s, OCH3) 6.66 - 6.68 (2H, m, H-5 and H-8), 
1.08 (2H, m, Ph), 7.31 (8H, m, Ph).  
13C NMR (CDCl3): δC 22.6 (CH3), 29.6 (C-4), 32.0 (CH2Ph), 43.4 (C-3), 55.9 (2 x OCH3), 





128.6 (C-Ph), 128.8 (C-2′, C-6′, C-4b), 129.5 (C-4a), 138.5 (C-1′ & C1-Ph), 147.1 (C-7), 
149.4 (C-6). 
HR-ESI-MS (positive ionization mode), m/z found 388.2285 [M+H]+; calculated for 
C26H30NO2 388.2277. 
IR: νmax (neat)/ cm-1 1093, 1592, 2975. 
 
4.2.21(S)-N-[2-(3,4-Dimethoxyphenyl)ethyl]-N-(1-phenylethylamine)- 






A saturated aq. Na2CO3 - DCM mixture, (1:1, 6 mL), S-36 (100 mg, 0.4 mmol) and 
phenylacetyl chloride (0.05 mL, 0.4 mmol) was stirred at room temperature overnight. The 
solution was extracted with DCM (3 x 10 mL) and washed with water and brine and dried 
with MgSO4 and concentrated under vacuum.  The product S-134 was obtained as a yellow 
oil (126 mg, 89%) and whose NMR spectra was similar to those of R-134. 
[ ] 	= +43.9 (1.1, CHCl3). 
1H NMR (CDCl3): δH 1.45 (3H, d, J = 7.0 Hz, CHCH3), 2.15 (1H, m, CH2CH2N), 2.30 (1H, 
m, CH2CH2N), 2.56 (1H, m, CH2CH2N), 2.74 (1H, m, CH2CH2N), 3.23 (2H, m, CH2CO), 
3.80 (3H, s, OCH3), 3.81 (3H, s, OCH3), 3.82 (2H, s, CH2CO), 5.20 (1H, q, J = 7.0 Hz, 
CHCH3), 6.52 (3H, m, H-2, H-5-H-6), 7.38 (13H, m, Ph).  
13C NMR (CDCl3): δC 17.8 (CHCH3), 34.3 (CH2CH2N), 36.7 (CH2CH2N), 45.5 (CH2CO), 
55.8 (OCH3), 55.9 (OCH3), 56.0 (CHCH3), 126.9-129.5 (C-Ph), 147.0 (C-4), 149.0 (C-3), 
171.3 (CO).  
HR-ESI-MS (positive ionization mode), m/z found 426.2030 [M+Na]+; calculated for 
C26H29NaNO3 426.2045. 












The title compound was synthesized by dissolving (S-134) (154 mg, 0.4 mmol) in 
anhydrous MeCN (10 mL) containing 3Å molecular sieves. Excess POCl3 (0.11 mL, 1.2 
mmol) was added and the reaction mixture was stirred for 1 h under a nitrogen atmosphere.  
The reaction mixture was cooled to room temperature followed by the evaporation of 
MeCN and excess POCl3. The resulting crude mixture of the dihydroisoquinolinium salt (S-
135)  was dissolved in anhydrous MeOH (10 mL) containing 3 Å molecular sieves, 
whereupon NaBH4 (45 mg, 1.2 mmol) in MeOH was added and stirred for 2 h at room 
temperature.  The crude mixture was purified by centrifugal chromatography (EtOAc-
MeOH, 5:2). The product (S-136) was isolated as a brown oil (87 mg, in 59%).  
[ ] 	= -83.7 (1.6, CHCl3). 
1H NMR (CDCl3): δH 1.47 (3H, d, J = 7.4 Hz, CHCH3Ph), 1.98 (2H, m, CH2CH2N), 2.35 
(2H, t, J = 7.2 Hz, CH2CH2N), 2.77 (2H, m, CH2Ph), 3.85 (6H, s, 2 x OCH3), 4.03 (1H, 
m, CHCH3Ph), 4.21 (1H, t, J = 6.1 Hz, H-1), 6.62 (2H, m, H-5 & H-8), 7.27 – 7.39 (Ph).  
13C NMR (CDCl3): δC 22.7 (CHCH3Ph), 32.0 (C-4), 41.3 (CH2Ph), 41.9 (C-3), 42.6 
(CHCH3Ph), 50.3 (C-1), 55.4 (OCH3), 55.8 (OCH3), 111.3 (C-5), 111.5 (C-8), 127.3 (C-
4′), 127.5 (C-4′′), 128.1 (C-2′ & C-6′), 128.7 (C-3′′ & C-5′′), 128.7 (C-3′ & C-5′), 129.2 
(C-4b, C-2′′&C-6′′), 130.0 (C-1), 136.3 (C-4a), 138.8 (C-1′′), 135.3 (C-1′), 145.7 (C-7), 
146.4 (C-6).  
HR-ESI-MS (positive ionization mode), m/z found 388.2283 [M+H]+; calculated for 
C26H30NO2 388.2275. 













A saturated aq. Na2CO3 - DCM (1:1, 6 mL) mixture containing the amine 119 (325 mg, 1.0 
mmol) and phenylacetyl chloride (122) (0.1 mL, 1.0 mmol) was stirred at room temperature 
overnight. After cooling to room temperature the organic layer was extracted with DCM (3 
x 10 mL). The combined extracts were washed successively with water and brine and dried 
MgSO4 before being concentrated under reduced pressure.  The product 137 was obtained 
as a yellow oil (390 mg, 87%).  
[ ] 	= -73.2 (1.4, CHCl3). 
1H NMR (CDCl3): δH 2.11 (4H, m, CHCH2CH2CH2Ph), 2.71 – 2.81 (8H, m, CH2CH2N, 
CHCH2CH2CH2Ph, CH2Ph), 3.63 (3H, s, OCH3), 3.65 (3H, s, OCH3), 4.14 (1H, t, J = 6.5 
Hz, CHCH2), 7.04 (2H, m, H-2 & H-6), 7.18 - 7.20 (7H, H-Ar). 
HR-ESI-MS (positive ionization mode), m/z found 451.9938 [M+Na]+; calculated for 
C28H31NaNO3 451.9920. 













The title compound was synthesized by dissolving 137 (120 mg, 0.3 mmol) in anhydrous 
MeCN (10 mL) with 3Å molecular sieves. Excess POCl3 (0.08 mL, 0.9 mmol) was added 
and the reaction mixture was stirred for 1 h under a nitrogen atmosphere.  The reaction 
mixture was cooled to room temperature followed by the evaporation of MeCN and excess 
POCl3. The resulting crude mixture of the dihydroisoquinolinium salt 138 was dissolved in 
anhydrous MeOH (10 mL), 3 Å molecular sieves were added and the mixture stirred for 2 h 
at room temperature.  The crude mixture could not be purified since there were multiple 
spots on the TLC.  
 
4.3 Synthesis of Reagents 












To a vigorously stirring solution of 2-iodobenzoic acid (1.1 g, 34.5 mmol) in H2SO4 (20 
mL, 0.73 M) at 0 ºC, KBrO3 (1 g, 4.6 mmol) was added slowly and then allowed to reach 
room temperature. The reaction mixture was heated to 65 °C and allowed to stir for 
further 3 h. The resulting off-white precipitate was filtered via suction filtration and 
washed with cold water and allowed to dry. The precipitate was recrystallized from 
methanol. White needle-shaped crystals of the product (105) (0.88 g, 91%) were 
obtained.6,7 
Mp: 229.4 – 232.1 (Lit8: 233 °C). 
1H NMR (DMSO-d6): δH 7.63 (1H, t, J = 7.7 Hz, H-3), 7.78 (1H, t, J = 7.4 Hz, H-2), 7.83 
(1H, d, J = 7.7 Hz, H-4), 7.94 (1H, d, J = 7.8 Hz, H-1). 
13C NMR (CDCl3): δC 121.4 (C-1), 127.2 (C-4), 131.3 (C-4a), 132.0 (C-3), 132.5 (C-2), 
135.4 (C-1a), 167.0 (C-5). 






IR: νmax (neat)/ cm-1 1433, 1669, 3089. 







To a cold (0 ºC) solution of triphenylphoshine (10.0 g, 38.0 mmol) in toluene (20 mL), 
methyl iodide (0.99 mL, 51.0 mmol) was added dropwise. The reaction mixture was stirred 
at room temperature overnight. The solid material was collected by filtration followed by 
washing with cold toluene. The product was dried in a vacuum oven to give the title 
compound 140 (9.8 g, 66% yield) as a white powder.  
31P NMR (DMSO-d6): δP 23.02. 
HR-ESI-MS (positive ionization mode): m/z found 278.1153 [M+H]+; calculated for 
C19H19P 278.1140. 
IR: νmax (neat)/ cm-1 1112, 1219, 1439. 
 
4.3.3 Silica chloride (141) 
To a well-stirred slurry of silica gel (5 g) in DCM (13.0 mL), SOCl2 (4.3 mL) was added 
dropwise at room temperature. Vast amounts of SO2 and HCl gas were evolved as by-
products and removed using a delivering tube. The reaction mixture was allowed to stir for 
1 h at room temperature whereupon the SiO2-Cl was collected by gravity filtration as a 
greyish solid SiO2-Cl (7.25 g, 96%) which was allowed to dry at room temperature and 
finally kept in a sealed vial.9,10  
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Plate 1: 1H NMR spectrum of (S)-N-[2-(3,4-dimethoxyphenyl)ethyl]-1-phenylethylamine 
(R-31) in CDCl3 
 
Plate 2: 13C NMR spectrum of (S)-N-[2-(3,4-dimethoxyphenyl)ethyl]-1-phenylethylamine 



































































































































































































Plate 3:1H NMR spectrum of 3,4-dimethoxybenzaldehyde (61)in CDCl3 
 














































































































Plate 5: 1H NMR spectrum of 3,4-dimethoxyphenylacetaldehyde (79) in CDCl3 
 
 




































































































































































































































































































































































































Plate 9: 1H NMR spectrum of 1,2-dimethoxy-4-vinylbenzene (95)  in CDCl3 
 




























































Plate 11: 1H NMR spectrum of 2-(3,4-dimethoxyphenyl)ethanol (96) in CDCl3 
 
 













































































































Plate 13: 1H NMR spectrum of IBX (105) in DMSO-d6 
 

























































































Plate 15: 1H NMR spectrum of (1S)-1-phenyl-N-(2-phenylethyl)ethanamine (109) in 
CDCl3 
 






















































































































































































Plate 18: 1H NMR spectrum of 2-(3,4-dimethoxyphenyl)ethyl 4-methylbenzenesulfonate 













Plate 19: 13C NMR spectrum of 2-(3,4-dimethoxyphenyl)ethyl 4-methylbenzenesulfonate 















































































































































































Plate 20: 1H NMR spectrum of  (S)-N-[2-(3,4-dimethoxyphenyl)ethyl]-1,2,3,4-
tetrahydronaphthalen-1-amine (119) in CDCl3 
 
Plate 21: 13C NMR spectrum of (S)-N-[2-(3,4-dimethoxyphenyl)ethyl]-1,2,3,4-




























































































































































Plate 22: 1H NMR spectrum of 6,7-dimethoxy-1-(4-methoxyphenyl)-1,2,3,4-
tetrahydroisoquinoline (121) in CDCl3 
 
Plate 23: 13C NMR spectrum of 6,7-dimethoxy-1-(4-methoxyphenyl)-1,2,3,4-



















































































































































































Plate 24: 1H NMR spectrum of N-[2-(3,4-dimethoxyphenyl)ethyl]-2-phenylacetamide 
(123) in CDCl3 
 
 
Plate 25: 13C NMR spectrum of N-[2-(3,4-dimethoxyphenyl)ethyl]-2-phenylacetamide 















































































































































































































































































Plate 27: 1H NMR spectrum of 1-benzyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline 
(125) in CDCl3 
 
Plate 28: 13C NMR spectrum of 1-benzyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline 


































































































































































Plate 29: 1H NMR spectrum of N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(4-
methoxyphenyl)acetamide (127) in CDCl3 
 
Plate 30: 13C NMR spectrum of N-[2-(3,4-dimethoxyphenyl)ethyl]-2-(4-






























































































































































































Plate 31: 1H NMR spectrum of 6,7-dimethoxy-1-(4-methoxybenzyl)-1,2,3,4-
tetrahydroisoquinoline (129) in CDCl3 
 
 
Plate 32: 13C NMR spectrum of 6,7-dimethoxy-1-(4-methoxybenzyl)-1,2,3,4-



























































































































































































Plate 33: 1H NMR spectrum of N-[2-(3,4-dimethoxyphenyl)ethyl]propanamide (131) in 
CDCl3 
 
























































































































Plate 35: 1H NMR spectrum of 1-ethyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline 
(133) in CDCl3 
 
Plate 36: 13C NMR spectrum of 1-ethyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline 

















































































































































Plate 37: 1H NMR spectrum of 1R)-1-benzyl-6,7-dimethoxy-N-(1-phenylethyl)-1,2,3,4-
tetrahydroisoquinoline (R-136) in CDCl3 
 
 
Plate 38: 13C NMR spectrum of 1R)-1-benzyl-6,7-dimethoxy-N-(1-phenylethyl)-1,2,3,4-



















































































































































Plate 39: 31P NMR spectrum of methyltriphenylphosphonium iodide (140) in DMSO-d6 
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